Literature DB >> 34580158

Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging.

Adam Kimbrough1,2,3, Marsida Kallupi1,3, Lauren C Smith1,3, Sierra Simpson1,3, Andres Collazo4, Olivier George5,3.   

Abstract

Numerous brain regions have been identified as contributing to withdrawal behaviors, but it is unclear the way in which these brain regions as a whole lead to withdrawal. The search for a final common brain pathway that is involved in withdrawal remains elusive. To address this question, we implanted osmotic minipumps containing either saline, nicotine (24 mg/kg/d), cocaine (60 mg/kg/d), or methamphetamine (4 mg/kg/d) for one week in male C57BL/6J mice. After one week, the minipumps were removed and brains collected 8 h (saline, nicotine, and cocaine) or 12 h (methamphetamine) after removal. We then performed single-cell whole-brain imaging of neural activity during the withdrawal period when brains were collected. We used hierarchical clustering and graph theory to identify similarities and differences in brain functional architecture. Although methamphetamine and cocaine shared some network similarities, the main common neuroadaptation between these psychostimulant drugs was a dramatic decrease in modularity, with a shift from a cortical-driven to subcortical-driven network, including a decrease in total hub brain regions. These results demonstrate that psychostimulant withdrawal produces the drug-dependent remodeling of functional architecture of the brain and suggest that the decreased modularity of brain functional networks and not a specific set of brain regions may represent the final common pathway associated with withdrawal.
Copyright © 2021 Kimbrough et al.

Entities:  

Keywords:  addiction; functional connectivity; graph theory; iDISCO; neural activity; withdrawal

Mesh:

Substances:

Year:  2021        PMID: 34580158      PMCID: PMC8570684          DOI: 10.1523/ENEURO.0208-19.2021

Source DB:  PubMed          Journal:  eNeuro        ISSN: 2373-2822


Significance Statement

A key aspect of treating drug abuse is understanding similarities and differences of how drugs of abuse affect the brain. In the present study, we examined how the brain is altered during withdrawal from psychostimulants. We found that each drug produced a unique pattern of activity in the brain, but that brains in withdrawal from cocaine and methamphetamine shared similar features. Interestingly, we found the major common link between withdrawal from all psychostimulants, when compared with controls, was a shift in the broad organization of the brain in the form of reduced modularity. Reduced modularity has been shown in several brain disorders, including traumatic brain injury, and dementia, and may be the common link between drugs of abuse.

Introduction

Psychostimulants are a class of highly addictive and commonly abused drugs that includes cocaine, nicotine, and methamphetamine (Balfour, 2008; Phillips et al., 2014). A large number of brain regions have been implicated in withdrawal associated with psychostimulant use (Kalivas and McFarland, 2003; Robinson and Kolb, 2004; Kalivas, 2007; Everitt et al., 2008; Jedynak et al., 2012; Koob and Volkow, 2016; Bobadilla et al., 2017). However, the complete neural network that is associated with psychostimulant withdrawal remains understudied, and the search for a common brain pathway that is responsible for psychostimulant withdrawal remains elusive. Common features of withdrawal may not be found at the brain region level but rather at the network level. The identification of changes in neural network structure that are caused by psychostimulant withdrawal may be critical to understanding the ways in which these drugs affect the brain. Previous studies identified changes in network function after psychostimulant use (Tomasi et al., 2010; Konova et al., 2013, 2015; Ma et al., 2015), but these analyses focused on macroscale changes and not the mesoscale level, or they focused on preselected regions of interest. The present study sought to identify the ways in which withdrawal from different commonly abused psychostimulants alters functional architecture of the brain. We hypothesized that withdrawal from psychostimulants would result in changes in functional neural networks and decrease modular structuring of the brain. We further hypothesized that each psychostimulant that was examined herein (i.e., methamphetamine, nicotine, and cocaine) would have a unique neural network that is associated with withdrawal. We measured single-cell whole-brain activity using Fos as a marker for neuronal activation in mice that underwent withdrawal from chronic psychostimulant (cocaine, methamphetamine, and nicotine) administration. To accomplish this, mice were implanted with osmotic minipumps for one week to induce dependence to each drug. Following one-week minipumps were removed and brains were collected from mice during acute withdrawal. This method of acute withdrawal was chosen to control the amount of drug each animal received and create strong dependence in a short period of time. The psychostimulant doses were chosen based on previous studies that reported rewarding effects during use and observed withdrawal-like symptoms after the cessation of chronic exposure for each drug (Johnson et al., 2008; Fish et al., 2010; Eisener-Dorman et al., 2011; Stoker and Markou, 2011; Stoker et al., 2012; Tracy et al., 2016; Zhu et al., 2017). We then used single-cell whole-brain activity to identify coactivation patterns of brain regions in the network that was associated with each treatment using hierarchical clustering. The functional connectivity measures were used to determine the modular structuring of each network. Graph theory was then used to further characterize each network to determine the brain regions that are most heavily involved in intramodular and intermodular connectivity of the functional network.

Materials and Methods

Animals

Male C57BL/6J mice were bred at The Scripps Research Institute. They were 20–30 g and 60 d old at the start of the experiment. The mice were maintained on a 12/12 h light/dark cycle with ad libitum access to food and water. All of the procedures were conducted in strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by The Scripps Research Institute Institutional Animal Care and Use Committee and by the Institutional Animal Care and Use Committee of the University of California.

Drugs

The doses were 4 mg/kg/d for methamphetamine, 24 mg/kg/d for nicotine, and 60 mg/kg/d for cocaine. These doses were chosen based on previous studies that indicated rewarding effects during use, resulting in withdrawal-like symptoms after the cessation of chronic use (Johnson et al., 2008; Fish et al., 2010; Eisener-Dorman et al., 2011; Stoker and Markou, 2011; Stoker et al., 2012; Tracy et al., 2016; Zhu et al., 2017). Each drug was dissolved in saline, and the pH was adjusted to 7.4. The drugs were loaded into osmotic minipumps (Alzet; model 1002). The minipumps sat overnight in saline before insertion to ensure that drug delivery would begin immediately.

Minipump implantation and removal

The mice were split into four groups for the experiment: methamphetamine withdrawal group (n = 5), nicotine withdrawal group (n = 5), cocaine withdrawal group (n = 5), and saline control group (n = 4). Each mouse was surgically implanted with an osmotic minipump for methamphetamine, nicotine, cocaine, and saline based on group assignment. The minipumps were implanted in the lower back of each mouse under anesthesia. After brief recovery, the mice were returned to their home cages. The mice remained in their home cages for one week to allow for chronic infusion of the drug. After one week, the minipumps were surgically removed under anesthesia to allow for drug washout and withdrawal to begin. Mice in the nicotine, cocaine, and saline groups were perfused 8 h after removal of the minipumps. Mice in the methamphetamine group were perfused 12 h after removal of the minipumps. These time points were chosen to represent an acute withdrawal period from each drug (e.g., a minimum of 4 h without the drug present) and based on the half-life of each drug in mice (Benuck et al., 1987; Cho et al., 2001; Norman et al., 2007; Siu and Tyndale, 2007; Shabani et al., 2012).

Tissue collection

The mice were deeply anesthetized and perfused with 15 ml of PBS followed by 50 ml of 4% formaldehyde. The brains were postfixed in formaldehyde overnight. The next day, the brains were washed for 30 min three times with PBS and transferred to a PBS/0.1% azide solution at 4°C for 2–3 d before processing via iDISCO+.

iDISCO+

The iDISCO+ procedure was performed as reported previously (Renier et al., 2014, 2016). The associated immunostaining, sample clearing, and image collection for iDISCO+ are detailed below. For an experimental design overview see Figure 1.
Figure 1.

, Experimental design. Mice were surgically implanted with an osmotic minipump that contained either saline or a psychostimulant (60 mg/kg/d cocaine, 4 mg/kg/d methamphetamine, or 24 mg/kg/d nicotine). They were then returned to their home cage for one week. After one week, the minipumps were surgically removed, and the mice were returned to their home cage until brain tissue was collected 8 h later (saline, cocaine, nicotine) or 12 h later (methamphetamine). Brains were then processed for whole-brain Fos immunohistochemistry and clearing via iDISCO+ and then imaged on a light-sheet microscope. Fos values were detected and registered to the Allen Brain Atlas using ClearMap Renier et al., 2016. Pearson correlations were then calculated to determine functional coactivation among brain regions. Brain regions were then grouped into modules based on their coactivation patterns through hierarchical clustering. Graph theory analyses was then performed to identify brain regions that are heavily involved in intramodular and intermodular connectivity. , Workflow diagram of registration to the Allen Brain Atlas using ClearMap. Registration is performed by matching a the autofluorescence to a preregistered two-photon image set that has been matched to brain region delineations of the Allen Brain Atlas. The brain region demarcations mapped to the autofluorescence are then used to map onto the Fos values taken from the corresponding frame. Auto Fluo = Autofluorescence.

, Experimental design. Mice were surgically implanted with an osmotic minipump that contained either saline or a psychostimulant (60 mg/kg/d cocaine, 4 mg/kg/d methamphetamine, or 24 mg/kg/d nicotine). They were then returned to their home cage for one week. After one week, the minipumps were surgically removed, and the mice were returned to their home cage until brain tissue was collected 8 h later (saline, cocaine, nicotine) or 12 h later (methamphetamine). Brains were then processed for whole-brain Fos immunohistochemistry and clearing via iDISCO+ and then imaged on a light-sheet microscope. Fos values were detected and registered to the Allen Brain Atlas using ClearMap Renier et al., 2016. Pearson correlations were then calculated to determine functional coactivation among brain regions. Brain regions were then grouped into modules based on their coactivation patterns through hierarchical clustering. Graph theory analyses was then performed to identify brain regions that are heavily involved in intramodular and intermodular connectivity. , Workflow diagram of registration to the Allen Brain Atlas using ClearMap. Registration is performed by matching a the autofluorescence to a preregistered two-photon image set that has been matched to brain region delineations of the Allen Brain Atlas. The brain region demarcations mapped to the autofluorescence are then used to map onto the Fos values taken from the corresponding frame. Auto Fluo = Autofluorescence.

Immunostaining

Fixed samples were washed in 20% methanol (in double-distilled H2O) for 1 h, 40% methanol for 1 h, 60% methanol for 1 h, 80% methanol for 1 h, and 100% methanol for 1 h twice. The samples were then precleared with overnight incubation in 33% methanol and 66% dichloromethane (DCM; Sigma, catalog #270997-12X100ML). The next day, the samples were bleached with 5% H2O2 (1 volume of 30% H2O2 for 5 volumes of methanol, ice cold) at 4°C overnight. After bleaching, the samples were slowly re-equilibrated at room temperature and rehydrated in 80% methanol in double-distilled H2O for 1 h, 60% methanol for 1 h, 40% methanol for 1 h, 20% methanol for 1 h, PBS for 1 h, and PBS and 0.2% Triton X-100 for 1 h twice. The samples were then incubated in PBS, 0.2% Triton X-100, 20% dimethylsulfoxide (DMSO), 0.3 m glycine at 37°C for 2 d and then blocked in PBS, 0.2% Triton X-100, 10% DMSO, and 6% donkey serum at 37°C for 2 d. The samples were then incubated in rabbit anti c-fos (1:2000; Synaptic Systems catalog #226003) in PBS-0.2% Tween with 10 μg, ml heparin (PTwH), and 5% DMSO/3% donkey serum at 37°C for 7 d. The samples were then washed in PTwH for 24 h (five changes of the PTwH solution over that time) and incubated in donkey anti-rabbit Alexa Fluor 647 (1:500; Invitrogen, catalog #A31573) in PTwH/3% donkey serum at 37°C for 7 d. The samples were finally washed in PTwH for 1 d before clearing and imaging.

Sample clearing

Immunolabeled brains were cleared using the procedure of Renier et al. (2016). The samples were dehydrated in 20% methanol in double-distilled H2O for 1 h, 40% methanol for 1 h, 60% methanol for 1 h, 80% methanol for 1 h, 100% methanol for 1 h, and 100% methanol again overnight. The next day, the samples were incubated for 3 h in 33% methanol/66% DCM until they sank to the bottom of the incubation tube. The methanol was then washed for 20 min twice in 100% DCM. Finally, the samples were incubated in dibenzyl ether (DBE; Sigma, catalog #108014-1KG) until clear and then stored in DBE at room temperature until imaged.

Image acquisition

Left hemispheres of cleared samples were imaged in the sagittal orientation (right lateral side up). A single hemisphere was imaged as done in previous studies to avoid the need to stitch images or analyze separate image stacks for the same sample (Renier et al., 2014, 2016). Future studies examining both hemispheres would provide interesting additional results. Samples were imaged on a light-sheet microscope (Ultramicroscope II, LaVision Biotec) equipped with an sCMOS camera (Andor Neo) and 2×/0.5 objective lens (MVPLAPO 2×) equipped with a 6-mm working distance dipping cap. Imspector Microscope controller v144 software was used. The microscope was equipped with an NKT Photonics SuperK EXTREME EXW-12 white light laser with three fixed light sheet generating lenses on each side. Scans were made at 0.8× magnification (1.6× effective magnification) with a light sheet numerical aperture of 0.148. Excitation filters of 480/30, 560/40, and 630/30 nm were used. Emission filters of 525/50, 595/40, and 680/30 nm were used. The samples were scanned with a step size of 3 μm using dynamic horizontal scanning from one side (the right) for the 560- and 630-nm channels (20 acquisitions per plane with 240-ms exposure, combined into one image using the horizontal adaptive algorithm) and without horizontal scanning for the 480-nm channel using two-sided illumination (100-ms exposure for each side, combined into one image using the blending algorithm). To accelerate acquisition, both channels where acquired in two separate scans. The imaging resolution (x = 4 μm, y = 4 μm, z = 3 μm) was selected to minimize imaging time without loss in terms of sensitivity or selectivity of the cell detection process or brain segmentation. The approach of clearing, alignment, cell detection, and registration has been validated in great detail in the original Renier et al. (2016) paper and shows that cell count obtained using ClearMap is 99% similar to manual detection by a trained user (Renier et al., 2016) when using a conservative cell voxel size threshold of 20 pixel (as in our study). The cell segmentation parameters and intensity threshold used to identify Fos-positive cells in this study are the default settings included in the ClearMap package (Renier et al., 2016) without further validation, but visual confirmation was made manually on every brain to verify appropriate alignment to the reference atlas and to verify that thresholding and pixel detection were set to maximize the number of cells detected while ensuring that cells were not double counted. To account for micro-movements of the samples that may occur between scans, three-dimensional image affine registration was performed to align both channels using ClearMap (Renier et al., 2016). Representative images of Fos collected can be seen in Figure 2.
Figure 2.

, Lateral to medial sagittal representative sections of the brain and zoomed in representative hippocampal subsections for each treatment. , Comparisons of Fos values for saline versus each treatment in the dentate gyrus. See Extended Data Figure 2-2 for raw Fos values and Extended Data Figure 2-1 for comparisons of raw Fos for treatments versus saline.

, Lateral to medial sagittal representative sections of the brain and zoomed in representative hippocampal subsections for each treatment. , Comparisons of Fos values for saline versus each treatment in the dentate gyrus. See Extended Data Figure 2-2 for raw Fos values and Extended Data Figure 2-1 for comparisons of raw Fos for treatments versus saline. Fos counts of brain regions showing significant differences between a treatment and saline. Download Figure 2-1, TIF file. Table of raw Fos values and group SEMs for each treatment. Download Figure 2-2, XLS file.

Data analysis

Identification of activated brain regions

Images that were acquired from the light-sheet microscope were analyzed from the end of the olfactory bulbs (the olfactory bulbs were not included in the analysis) to the beginning of the hindbrain and cerebellum. Counts of Fos-positive nuclei from each sample were identified for each brain region using ClearMap (Renier et al., 2016). ClearMap uses autofluorescence that is acquired in the 488-nm channel to align the brain to the Allen Mouse Brain Atlas (Allen Institute for Brain Science, 2004) and then registers Fos counts to regions that are annotated by the atlas. ClearMap has been validated and used now in several recent studies to identify labeled neurons and quantify the number labeled in a given brain region (Liebmann et al., 2016; Renier et al., 2016; Kimbrough et al., 2020; Kirst et al., 2020; Qian et al., 2021). For raw Fos counts and information on brain regions showing significant differences between saline and treatment Fos levels assessed by traditional comparison see the Extended Data Figures 2-1 and 2-2. A potential confound of the present approach is that possible errors in atlas registration, although unlikely, are would impact data from smaller brain regions more than larger brain regions. The data were normalized to a log10 value to reduce variability and bring brain regions with high numbers (e.g., thousands) and low numbers (e.g., tens to hundreds) of Fos counts to a similar scale.

Identification of functional connectivity within individual networks

Separate interregional Pearson correlations were then calculated using Statistica software (Tibco) across animals in the saline, cocaine, methamphetamine, and nicotine groups to compare the log10 Fos data from each brain region to each of the other brain regions. See Table 1 for a list of brain regions, their abbreviations, and their Allen atlas grouping. It should be noted that connectivity throughout refers to functional connectivity of brain regions and not structural connectivity.
Table 1

Brain regions list

Brain regionAbbreviationAllen Group name
Agranular insular area posterior partAIpCortical plate
Agranular insular area ventral partAIvCortical plate
Anterior cingulate area dorsal partACAdCortical plate
Anterior cingulate area ventral partACAvCortical plate
Anterior olfactory nucleusAONCortical plate
Anterolateral visual areaVISalCortical plate
Anteromedial visual areaVISamCortical plate
Cortical amygdalar area posterior partCOApCortical plate
Dentate gyrusDGCortical plate
Dorsal auditory areaAUDdCortical plate
Dorsal peduncular areaDPCortical plate
Ectorhinal areaECTCortical plate
Entorhinal area lateral partENTlCortical plate
Entorhinal area medial partENTmCortical plate
Fasciola cinereaFCCortical plate
Field CA1CA1Cortical plate
Field CA2CA2Cortical plate
Field CA3CA3Cortical plate
Frontal pole cerebral cortexFRPCortical plate
Gustatory areasGUCortical plate
Induseum griseumIGCortical plate
Infralimbic areaILACortical plate
Lateral visual areaVISlCortical plate
Nucleus of the lateral olfactory tractNLOTCortical plate
Orbital area lateral partORBlCortical plate
Orbital area medial partORBmCortical plate
Orbital area ventrolateral partORBvlCortical plate
ParasubiculumPARCortical plate
Perirhinal areaPERICortical plate
Piriform areaPIRCortical plate
Piriform-amygdalar areaPAACortical plate
Posterior auditory areaAUDpoCortical plate
Posterolateral visual areaVISplCortical plate
Posteromedial visual areaVISpmCortical plate
Postpiriform transition areaTRCortical plate
PostsubiculumPOSTCortical plate
Prelimbic areaPLCortical plate
PresubiculumPRECortical plate
Primary auditory areaAUDpCortical plate
Primary motor areaMOpCortical plate
Primary somatosensory area barrel fieldSSp-bfdCortical plate
Primary somatosensory area lower limbSSp-llCortical plate
Primary somatosensory area mouthSSp-mCortical plate
Primary somatosensory area noseSSp-nCortical plate
Primary somatosensory area trunkSSp-trCortical plate
Primary somatosensory area upper limbSSp-ulCortical plate
Primary visual areaVISpCortical plate
Retrosplenial area dorsal partRSPdCortical plate
Retrosplenial area lateral agranular partRSPaglCortical plate
Retrosplenial area ventral partRSPvCortical plate
Secondary motor areaMOsCortical plate
SubiculumSUBCortical plate
Supplemental somatosensory areaSSsCortical plate
Taenia tectaTTCortical plate
Temporal association areasTEaCortical plate
Ventral auditory areaAUDvCortical plate
Visceral areaVISCCortical plate
Basolateral amygdalar nucleusBLACortical subplate
ClaustrumCLACortical subplate
Endopiriform nucleusEPCortical subplate
Lateral amygdalar nucleusLACortical subplate
Posterior amygdalar nucleusPACortical subplate
Anterior amygdalar areaAAAStriatum
Bed nucleus of the accessory olfactory tractBAStriatum
CaudoputamenCPStriatum
Central amygdalar nucleusCEAStriatum
Fundus of striatumFSStriatum
Intercalated amygdalar nucleusIAStriatum
Lateral septal complexLSXStriatum
Medial amygdalar nucleusMEAStriatum
Nucleus accumbensACBStriatum
Olfactory tubercleOTStriatum
Septofimbrial nucleusSFStriatum
Bed nuclei of the stria terminalisBSTPallidum
Diagonal band nucleusNDBPallidum
Globus pallidus external segmentGPePallidum
Globus pallidus internal segmentGPiPallidum
Magnocellular nucleusMAPallidum
Medial septal nucleusMSPallidum
Substantia innominataSIPallidum
Triangular nucleus of septumTRSPallidum
Anterior group of the dorsal thalamusATNThalamus
Anterodorsal nucleusADThalamus
Anteroventral nucleus of thalamusAVThalamus
Central lateral nucleus of the thalamusCLThalamus
Central medial nucleus of the thalamusCMThalamus
Dorsal part of the lateral geniculate complexLGdThalamus
Interanterodorsal nucleus of the thalamusIADThalamus
Interanteromedial nucleus of the thalamusIAMThalamus
Intergeniculate leaflet of the lateral geniculate complexIGLThalamus
Intermediodorsal nucleus of the thalamusIMDThalamus
Lateral dorsal nucleus of thalamusLDThalamus
Lateral habenulaLHThalamus
Lateral posterior nucleus of the thalamusLPThalamus
Medial geniculate complexMGThalamus
Medial habenulaMHThalamus
Mediodorsal nucleus of thalamusMDThalamus
Nucleus of reuniensREThalamus
Paracentral nucleusPCNThalamus
Parafascicular nucleusPFThalamus
Parataenial nucleusPTThalamus
Paraventricular nucleus of the thalamusPVTThalamus
Peripeduncular nucleusPPThalamus
Posterior complex of the thalamusPOThalamus
Posterior limiting nucleus of the thalamusPOLThalamus
Reticular nucleus of the thalamusRTThalamus
Submedial nucleus of the thalamusSMTThalamus
Subparafascicular nucleusSPFThalamus
Thalamus sensory-motor cortex relatedDORsmThalamus
Ventral anterior-lateral complex of the thalamusVALThalamus
Ventral medial nucleus of the thalamusVMThalamus
Ventral part of the lateral geniculate complexLGvThalamus
Ventral posterior complex of the thalamusVPThalamus
Ventral posterolateral nucleus of the thalamusVPLThalamus
Anterior hypothalamic nucleusAHNHypothalamus
Anterodorsal preoptic nucleusADPHypothalamus
Anteroventral periventricular nucleusAVPVHypothalamus
Anteroventral preoptic nucleusAVPHypothalamus
Arcuate hypothalamic nucleusARHHypothalamus
Dorsal premammillary nucleusPMdHypothalamus
Dorsomedial nucleus of the hypothalamusDMHHypothalamus
Lateral hypothalamic areaLHAHypothalamus
Lateral preoptic areaLPOHypothalamus
Mammillary bodyMBOHypothalamus
Medial preoptic areaMPOHypothalamus
Medial preoptic nucleusMPNHypothalamus
Median preoptic nucleusMEPOHypothalamus
Parastrial nucleusPSHypothalamus
Parasubthalamic nucleusPSTNHypothalamus
Paraventricular hypothalamic nucleusPVHHypothalamus
Paraventricular hypothalamic nucleus descending divisionPVHdHypothalamus
Periventricular hypothalamic nucleus posterior partPVpHypothalamus
Periventricular hypothalamic nucleus preoptic partPVpoHypothalamus
Periventricular zonePVZHypothalamus
Posterior hypothalamic nucleusPHHypothalamus
Preparasubthalamic nucleusPSTHypothalamus
Retrochiasmatic areaRCHHypothalamus
Subparaventricular zoneSBPVHypothalamus
Subthalamic nucleusSTNHypothalamus
Suprachiasmatic nucleusSCHHypothalamus
Supramammillary nucleusSUMHypothalamus
Supraoptic nucleusSOHypothalamus
Tuberal nucleusTUHypothalamus
Ventrolateral preoptic nucleusVLPOHypothalamus
Ventromedial hypothalamic nucleusVMHHypothalamus
Zona incertaZIHypothalamus
Anterior pretectal nucleusAPNMidbrain
Cuneiform nucleusCUNMidbrain
Inferior colliculusICMidbrain
Interpeduncular nucleusIPNMidbrain
Medial pretectal areaMPTMidbrain
Midbrain reticular nucleusMRNMidbrain
Midbrain reticular nucleus retrorubral areaRRMidbrain
Nucleus of DarkschewitschNDMidbrain
Nucleus of the brachium of the inferior colliculusNBMidbrain
Nucleus of the optic tractNOTMidbrain
Nucleus of the posterior commissureNPCMidbrain
Olivary pretectal nucleusOPMidbrain
Parabigeminal nucleusPBGMidbrain
Pedunculopontine nucleusPPNMidbrain
Periaqueductal grayPAGMidbrain
Posterior pretectal nucleusPPTMidbrain
Precommissural nucleusPRCMidbrain
Red nucleusRNMidbrain
Substantia nigra compact partSNcMidbrain
Substantia nigra reticular partSNrMidbrain
Superior colliculus motor relatedSCmMidbrain
Superior colliculus sensory relatedSCsMidbrain
Ventral tegmental areaVTAMidbrain
PonsPHindbrain
Pons motor relatedP-motHindbrain
Pontine reticular nucleusPRNrHindbrain
Vestibular nucleiVNCHindbrain
Ansiform lobuleANCerebellum
Central lobuleCENTCerebellum
CulmenCULCerebellum
ParaflocculusPFLCerebellum
Simple lobuleSIMCerebellum
Brain regions list

Hierarchical clustering

Previous rat and mouse studies that examined functional connectivity used five to eight animals (Wheeler et al., 2013; Orsini et al., 2018). The number of samples that are examined in functional connectivity studies is the number of potential functional connections (i.e., 178 total brain regions all connecting with each other for each treatment). Furthermore, hierarchical clustering organizes brain regions into modules by grouping regions that show a similar functional connectivity profile across all other brain regions. Thus, more total functional connections minimize the effect that an inaccurate brain region-to-brain region functional connection has on network organization and overall network structure. Interregional Pearson correlations were then used to calculate complete Euclidean distances between each pair of brain regions in each group of mice. The distance matrices were then hierarchically clustered using R Studio software by both row and column using the complete method to identify modules of functional connectivity within each treatment group. The hierarchical cluster dendrograms were trimmed at half the height of each given tree to split the dendrogram into specific modules. The result of a decrease in modularity that is attributable to psychostimulant use was consistent across multiple tree-cutting thresholds (Fig. 3).
Figure 3.

, Hierarchical clustering of complete Euclidean distance matrices for each treatment. Modules were determined by cutting each dendrogram at half of the maximal tree height. , Relative distance of each brain region relative to the others that were examined in saline control mice. In control mice, seven distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in cocaine mice. In cocaine mice, four distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in methamphetamine mice. In methamphetamine mice, three distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in nicotine mice. In nicotine mice, five distinct modules of coactivation were identified. For all distance matrices, each module is boxed in purple. For the individual brain regions that are listed in panels , see Table 6. , Number of modules in each treatment condition after cutting the hierarchical clustered dendrogram at different percentages of tree height. In all cases (except at extreme cutoff values; e.g., 90–100%), the psychostimulant networks showed lower modularity compared with the control network. See Extended Data Figure 3-1 for correlation matrices for each treatment.

, Hierarchical clustering of complete Euclidean distance matrices for each treatment. Modules were determined by cutting each dendrogram at half of the maximal tree height. , Relative distance of each brain region relative to the others that were examined in saline control mice. In control mice, seven distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in cocaine mice. In cocaine mice, four distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in methamphetamine mice. In methamphetamine mice, three distinct modules of coactivation were identified. , Relative distance of each brain region relative to the others that were examined in nicotine mice. In nicotine mice, five distinct modules of coactivation were identified. For all distance matrices, each module is boxed in purple. For the individual brain regions that are listed in panels , see Table 6. , Number of modules in each treatment condition after cutting the hierarchical clustered dendrogram at different percentages of tree height. In all cases (except at extreme cutoff values; e.g., 90–100%), the psychostimulant networks showed lower modularity compared with the control network. See Extended Data Figure 3-1 for correlation matrices for each treatment.
Table 6

Top to bottom order of brain regions in

NumberSaline hierarchical orderCocaine hierarchical order
1Retrosplenial area ventral partInferior colliculus
2Interanterodorsal nucleus of the thalamusPrimary visual area
3Anterior hypothalamic nucleusNucleus of the optic tract
4Posterolateral visual areaThalamus sensory-motor cortex related
5Precommissural nucleusRetrosplenial area dorsal part
6Superior colliculus motor relatedField CA1
7Cuneiform nucleusRetrosplenial area lateral agranular part
8Primary visual areaAnterior amygdalar area
9Superior colliculus sensory relatedAnterodorsal preoptic nucleus
10Parasubthalamic nucleusPrimary somatosensory area trunk
11Vestibular nucleiInteranteromedial nucleus of the thalamus
12Pons motor relatedSubparafascicular nucleus
13Lateral visual areaSuperior colliculus motor related
14Anterolateral visual areaPeriaqueductal gray
15Pontine reticular nucleusMagnocellular nucleus
16Periaqueductal grayBed nuclei of the stria terminalis
17Parastrial nucleusMidbrain reticular nucleus retrorubral area
18Fasciola cinereaVentromedial hypothalamic nucleus
19Anterodorsal nucleusVentral tegmental area
20Triangular nucleus of septumAnterior pretectal nucleus
21Lateral hypothalamic areaEndopiriform nucleus
22Dorsomedial nucleus of the hypothalamusOlfactory tubercle
23Nucleus accumbensTuberal nucleus
24Anterior group of the dorsal thalamusPiriform area
25Paraventricular hypothalamic nucleus descending divisionSubstantia innominata
26Medial pretectal areaVentral auditory area
27PostsubiculumDorsal part of the lateral geniculate complex
28ParasubiculumPosterolateral visual area
29Nucleus of the optic tractNucleus of the brachium of the inferior colliculus
30Midbrain reticular nucleus retrorubral areaSupraoptic nucleus
31Inferior colliculusCuneiform nucleus
32Anterior pretectal nucleusParaventricular nucleus of the thalamus
33Nucleus of DarkschewitschLateral visual area
34Field CA1Orbital area ventrolateral part
35Nucleus of the posterior commissureRed nucleus
36Fundus of striatumParastrial nucleus
37Dentate gyrusParasubthalamic nucleus
38PresubiculumAnterior hypothalamic nucleus
39Lateral posterior nucleus of the thalamusPosterior hypothalamic nucleus
40Parafascicular nucleusDorsal premammillary nucleus
41Peripeduncular nucleusLateral hypothalamic area
42Central lobuleRetrochiasmatic area
43Posterior pretectal nucleusPerirhinal area
44Lateral habenulaField CA3
45Nucleus of reuniensPosterior complex of the thalamus
46Ventral medial nucleus of the thalamusEntorhinal area lateral part
47Tuberal nucleusIntercalated amygdalar nucleus
48Periventricular hypothalamic nucleus posterior partSubstantia nigra compact part
49Posterior amygdalar nucleusBasolateral amygdalar nucleus
50Ventromedial hypothalamic nucleusPedunculopontine nucleus
51Posterior hypothalamic nucleusMedial preoptic area
52Arcuate hypothalamic nucleusEctorhinal area
53Subthalamic nucleusPrimary auditory area
54Paracentral nucleusTemporal association areas
55Substantia nigra compact partPontine reticular nucleus
56CulmenSubstantia nigra reticular part
57Pedunculopontine nucleusPons
58Interpeduncular nucleusMidbrain reticular nucleus
59Ventral posterior complex of the thalamusField CA2
60Induseum griseumSupramammillary nucleus
61Preparasubthalamic nucleusAnteromedial visual area
62Nucleus of the brachium of the inferior colliculusPosterior auditory area
63Red nucleusVisceral area
64Ventral tegmental areaPrimary motor area
65Substantia innominataParaventricular hypothalamic nucleus descending division
66Medial geniculate complexLateral dorsal nucleus of thalamus
67SubiculumPrimary somatosensory area barrel field
68Midbrain reticular nucleusOrbital area medial part
69Thalamus sensory-motor cortex relatedOrbital area lateral part
70Simple lobuleAnterolateral visual area
71ParaflocculusMedian preoptic nucleus
72Submedial nucleus of the thalamusSuprachiasmatic nucleus
73Subparafascicular nucleusSupplemental somatosensory area
74Olivary pretectal nucleusAgranular insular area posterior part
75Central lateral nucleus of the thalamusPrimary somatosensory area lower limb
76Medial septal nucleusSeptofimbrial nucleus
77Subparaventricular zoneAnterior cingulate area ventral part
78Anterior cingulate area ventral partParaventricular hypothalamic nucleus
79Secondary motor areaPrimary somatosensory area upper limb
80Suprachiasmatic nucleusSubmedial nucleus of the thalamus
81Periventricular zoneNucleus accumbens
82Septofimbrial nucleusClaustrum
83Paraventricular hypothalamic nucleusAgranular insular area ventral part
84Orbital area lateral partLateral septal complex
85Mediodorsal nucleus of thalamusTaenia tecta
86Posteromedial visual areaArcuate hypothalamic nucleus
87Retrosplenial area dorsal partOlivary pretectal nucleus
88Anteroventral periventricular nucleusDorsomedial nucleus of the hypothalamus
89Bed nuclei of the stria terminalisPrelimbic area
90Retrosplenial area lateral agranular partPeriventricular hypothalamic nucleus preoptic part
91Medial preoptic nucleusGustatory areas
92Anterodorsal preoptic nucleusFrontal pole cerebral cortex
93Primary motor areaSubparaventricular zone
94Lateral septal complexCaudoputamen
95Primary somatosensory area lower limbFundus of striatum
96Lateral dorsal nucleus of thalamusInfralimbic area
97Primary somatosensory area trunkMedial septal nucleus
98Anteromedial visual areaCentral lateral nucleus of the thalamus
99Lateral preoptic areaPosteromedial visual area
100Periventricular hypothalamic nucleus preoptic partLateral posterior nucleus of the thalamus
101Median preoptic nucleusCentral lobule
102Infralimbic areaCentral medial nucleus of the thalamus
103Primary somatosensory area upper limbPeriventricular hypothalamic nucleus posterior part
104Supramammillary nucleusCortical amygdalar area posterior part
105Gustatory areasNucleus of the lateral olfactory tract
106Taenia tectaEntorhinal area medial part
107Supraoptic nucleusZona incerta
108ClaustrumVentral anterior-lateral complex of the thalamus
109Anteroventral nucleus of thalamusPosterior amygdalar nucleus
110Prelimbic areaPostpiriform transition area
111Piriform areaLateral preoptic area
112Agranular insular area ventral partParabigeminal nucleus
113Dorsal peduncular areaIntergeniculate leaflet of the lateral geniculate complex
114Anterior cingulate area dorsal partVentral part of the lateral geniculate complex
115Orbital area medial partInteranterodorsal nucleus of the thalamus
116Orbital area ventrolateral partLateral amygdalar nucleus
117Anterior amygdalar areaVentrolateral preoptic nucleus
118CaudoputamenCentral amygdalar nucleus
119Primary somatosensory area barrel fieldDorsal auditory area
120Agranular insular area posterior partPreparasubthalamic nucleus
121Paraventricular nucleus of the thalamusVentral posterior complex of the thalamus
122Medial habenulaInterpeduncular nucleus
123Frontal pole cerebral cortexPeripeduncular nucleus
124Anterior olfactory nucleusDentate gyrus
125Central medial nucleus of the thalamusSuperior colliculus sensory related
126Intercalated amygdalar nucleusPiriform-amygdalar area
127Medial preoptic areaMedial geniculate complex
128Intermediodorsal nucleus of the thalamusPosterior pretectal nucleus
129Supplemental somatosensory areaNucleus of Darkschewitsch
130Primary somatosensory area nosePosterior limiting nucleus of the thalamus
131Primary somatosensory area mouthParacentral nucleus
132Visceral areaSubiculum
133Dorsal auditory areaAnsiform lobule
134Entorhinal area lateral partDiagonal band nucleus
135Field CA2Medial preoptic nucleus
136Mammillary bodyParaflocculus
137Posterior auditory areaMedial amygdalar nucleus
138Ventral auditory areaGlobus pallidus internal segment
139Temporal association areasNucleus of reuniens
140Ventral posterolateral nucleus of the thalamusMammillary body
141Ansiform lobuleGlobus pallidus external segment
142Entorhinal area medial partReticular nucleus of the thalamus
143Intergeniculate leaflet of the lateral geniculate complexPresubiculum
144Perirhinal areaPons motor related
145Reticular nucleus of the thalamusMediodorsal nucleus of thalamus
146Ectorhinal areaVentral medial nucleus of the thalamus
147Posterior complex of the thalamusRetrosplenial area ventral part
148Ventral anterior-lateral complex of the thalamusNucleus of the posterior commissure
149Dorsal part of the lateral geniculate complexParafascicular nucleus
150Primary auditory areaCulmen
151Postpiriform transition areaSimple lobule
152Magnocellular nucleusPrecommissural nucleus
153Globus pallidus internal segmentVestibular nuclei
154Lateral amygdalar nucleusParasubiculum
155Nucleus of the lateral olfactory tractVentral posterolateral nucleus of the thalamus
156Bed nucleus of the accessory olfactory tractBed nucleus of the accessory olfactory tract
157Dorsal premammillary nucleusAnteroventral preoptic nucleus
158Substantia nigra reticular partSubthalamic nucleus
159Zona incertaAnterior group of the dorsal thalamus
160Ventral part of the lateral geniculate complexParataenial nucleus
161Parabigeminal nucleusAnteroventral periventricular nucleus
162Field CA3Postsubiculum
163PonsAnterior cingulate area dorsal part
164Retrochiasmatic areaSecondary motor area
165Medial amygdalar nucleusTriangular nucleus of septum
166Parataenial nucleusPrimary somatosensory area mouth
167Interanteromedial nucleus of the thalamusMedial pretectal area
168Piriform-amygdalar areaAnterior olfactory nucleus
169Diagonal band nucleusPrimary somatosensory area nose
170Ventrolateral preoptic nucleusAnteroventral nucleus of thalamus
171Anteroventral preoptic nucleusPeriventricular zone
172Cortical amygdalar area posterior partIntermediodorsal nucleus of the thalamus
173Globus pallidus external segmentMedial habenula
174Posterior limiting nucleus of the thalamusAnterodorsal nucleus
175Endopiriform nucleusFasciola cinerea
176Olfactory tubercleDorsal peduncular area
177Central amygdalar nucleusInduseum griseum
178Basolateral amygdalar nucleusLateral habenula
NumberMethamphetamine hierarchical orderNicotine hierarchical order
1CaudoputamenVentral tegmental area
2Anterior amygdalar areaMidbrain reticular nucleus retrorubral area
3Parataenial nucleusSuperior colliculus motor related
4Periventricular hypothalamic nucleus preoptic partMidbrain reticular nucleus
5ClaustrumSimple lobule
6Medial habenulaPosterior hypothalamic nucleus
7Medial pretectal areaBasolateral amygdalar nucleus
8Ventral part of the lateral geniculate complexPedunculopontine nucleus
9Anteroventral preoptic nucleusSubparafascicular nucleus
10Parasubthalamic nucleusPons motor related
11Precommissural nucleusAnterior cingulate area dorsal part
12Parastrial nucleusParaventricular hypothalamic nucleus
13Anteroventral periventricular nucleusAnsiform lobule
14Central amygdalar nucleusPresubiculum
15Lateral amygdalar nucleusDorsal auditory area
16Endopiriform nucleusSupplemental somatosensory area
17Paraventricular nucleus of the thalamusPosterior limiting nucleus of the thalamus
18Intercalated amygdalar nucleusIntercalated amygdalar nucleus
19Intermediodorsal nucleus of the thalamusCentral amygdalar nucleus
20Postpiriform transition areaPosteromedial visual area
21Intergeniculate leaflet of the lateral geniculate complexLateral visual area
22Ventral auditory areaSupramammillary nucleus
23Bed nucleus of the accessory olfactory tractAnterolateral visual area
24Basolateral amygdalar nucleusGustatory areas
25Dorsal auditory areaMammillary body
26Primary somatosensory area barrel fieldPostsubiculum
27Magnocellular nucleusPeriventricular hypothalamic nucleus posterior part
28Primary somatosensory area nosePeriventricular zone
29Induseum griseumParaflocculus
30Anterior cingulate area ventral partPeripeduncular nucleus
31Anterior cingulate area dorsal partVestibular nuclei
32Pedunculopontine nucleusAnteroventral nucleus of thalamus
33Superior colliculus motor relatedEndopiriform nucleus
34Inferior colliculusCortical amygdalar area posterior part
35Entorhinal area lateral partPostpiriform transition area
36Substantia innominataPrelimbic area
37Nucleus accumbensIntermediodorsal nucleus of the thalamus
38Central lobuleLateral septal complex
39Posterior hypothalamic nucleusEntorhinal area lateral part
40Substantia nigra compact partVentrolateral preoptic nucleus
41Parabigeminal nucleusVisceral area
42ParasubiculumPosterior auditory area
43PresubiculumTemporal association areas
44PostsubiculumPrimary auditory area
45Diagonal band nucleusVentral auditory area
46Posterior auditory areaEctorhinal area
47Piriform-amygdalar areaPerirhinal area
48Periaqueductal grayPontine reticular nucleus
49Supramammillary nucleusMedial geniculate complex
50Anterolateral visual areaAnterior cingulate area ventral part
51Primary auditory areaClaustrum
52Ectorhinal areaPons
53Medial geniculate complexCentral lobule
54Temporal association areasRed nucleus
55Perirhinal areaRetrosplenial area lateral agranular part
56Agranular insular area ventral partLateral amygdalar nucleus
57Paraventricular hypothalamic nucleusRetrosplenial area dorsal part
58Subparafascicular nucleusInterpeduncular nucleus
59Subparaventricular zoneSuperior colliculus sensory related
60Paraventricular hypothalamic nucleus descending divisionInferior colliculus
61Nucleus of the brachium of the inferior colliculusRetrosplenial area ventral part
62Midbrain reticular nucleusPeriaqueductal gray
63Anterior hypothalamic nucleusVentral part of the lateral geniculate complex
64Peripeduncular nucleusNucleus of the brachium of the inferior colliculus
65SubiculumMediodorsal nucleus of thalamus
66Lateral visual areaCulmen
67Superior colliculus sensory relatedFasciola cinerea
68Midbrain reticular nucleus retrorubral areaAgranular insular area posterior part
69Nucleus of reuniensPiriform area
70Zona incertaCentral medial nucleus of the thalamus
71CulmenInteranteromedial nucleus of the thalamus
72Retrosplenial area lateral agranular partMedial pretectal area
73Lateral preoptic areaThalamus sensory-motor cortex related
74Anterior pretectal nucleusSeptofimbrial nucleus
75Posterior limiting nucleus of the thalamusVentral posterolateral nucleus of the thalamus
76Preparasubthalamic nucleusPiriform-amygdalar area
77Nucleus of the optic tractDorsomedial nucleus of the hypothalamus
78Medial preoptic areaDentate gyrus
79Thalamus sensory-motor cortex relatedAnteromedial visual area
80Medial preoptic nucleusPosterolateral visual area
81Dorsomedial nucleus of the hypothalamusFundus of striatum
82Red nucleusCaudoputamen
83Lateral septal complexArcuate hypothalamic nucleus
84Central medial nucleus of the thalamusParasubthalamic nucleus
85Interpeduncular nucleusSuprachiasmatic nucleus
86Reticular nucleus of the thalamusSubiculum
87Medial septal nucleusMedial septal nucleus
88Supraoptic nucleusNucleus of reuniens
89Periventricular hypothalamic nucleus posterior partSubstantia nigra compact part
90Interanteromedial nucleus of the thalamusDorsal premammillary nucleus
91Secondary motor areaParaventricular hypothalamic nucleus descending division
92Field CA2Central lateral nucleus of the thalamus
93Field CA3Nucleus of Darkschewitsch
94Posteromedial visual areaAnterior pretectal nucleus
95Primary motor areaParafascicular nucleus
96Anteromedial visual areaIntergeniculate leaflet of the lateral geniculate complex
97Medial amygdalar nucleusPrecommissural nucleus
98Piriform areaLateral habenula
99Posterior amygdalar nucleusMedial habenula
100Primary somatosensory area trunkParabigeminal nucleus
101Nucleus of the lateral olfactory tractNucleus of the optic tract
102Primary somatosensory area upper limbNucleus of the posterior commissure
103Primary somatosensory area lower limbOlivary pretectal nucleus
104Cortical amygdalar area posterior partAnterodorsal nucleus
105Visceral areaPosterior pretectal nucleus
106Agranular insular area posterior partParataenial nucleus
107Gustatory areasInduseum griseum
108Supplemental somatosensory areaTriangular nucleus of septum
109Primary somatosensory area mouthParaventricular nucleus of the thalamus
110Anterior olfactory nucleusInteranterodorsal nucleus of the thalamus
111Interanterodorsal nucleus of the thalamusMedial preoptic area
112Globus pallidus external segmentLateral preoptic area
113Anterodorsal preoptic nucleusNucleus accumbens
114Mediodorsal nucleus of thalamusVentral medial nucleus of the thalamus
115Ventral posterolateral nucleus of the thalamusGlobus pallidus internal segment
116Median preoptic nucleusLateral hypothalamic area
117Orbital area medial partAnteroventral periventricular nucleus
118Infralimbic areaMagnocellular nucleus
119Prelimbic areaDorsal peduncular area
120Taenia tectaPrimary motor area
121Fundus of striatumPrimary somatosensory area upper limb
122Lateral habenulaNucleus of the lateral olfactory tract
123Olivary pretectal nucleusMedian preoptic nucleus
124Entorhinal area medial partAnterodorsal preoptic nucleus
125Periventricular zonePrimary somatosensory area lower limb
126PonsZona incerta
127Dorsal premammillary nucleusAgranular insular area ventral part
128Pontine reticular nucleusField CA3
129Substantia nigra reticular partVentromedial hypothalamic nucleus
130Lateral hypothalamic areaParastrial nucleus
131Ventral tegmental areaPrimary visual area
132Dentate gyrusTaenia tecta
133Lateral posterior nucleus of the thalamusField CA1
134Subthalamic nucleusField CA2
135Suprachiasmatic nucleusAnteroventral preoptic nucleus
136Posterolateral visual areaRetrochiasmatic area
137Pons motor relatedInfralimbic area
138Ventromedial hypothalamic nucleusAnterior amygdalar area
139Retrochiasmatic areaPrimary somatosensory area nose
140Primary visual areaSubmedial nucleus of the thalamus
141Olfactory tuberclePrimary somatosensory area mouth
142Retrosplenial area dorsal partSecondary motor area
143Field CA1Subparaventricular zone
144Mammillary bodyPrimary somatosensory area trunk
145Globus pallidus internal segmentReticular nucleus of the thalamus
146Arcuate hypothalamic nucleusPeriventricular hypothalamic nucleus preoptic part
147Ventrolateral preoptic nucleusPreparasubthalamic nucleus
148Cuneiform nucleusAnterior group of the dorsal thalamus
149Tuberal nucleusPosterior amygdalar nucleus
150Submedial nucleus of the thalamusTuberal nucleus
151Dorsal part of the lateral geniculate complexParacentral nucleus
152Retrosplenial area ventral partCuneiform nucleus
153ParaflocculusSubthalamic nucleus
154Bed nuclei of the stria terminalisSubstantia nigra reticular part
155Anteroventral nucleus of thalamusEntorhinal area medial part
156Simple lobuleParasubiculum
157Fasciola cinereaOrbital area medial part
158Dorsal peduncular areaGlobus pallidus external segment
159Triangular nucleus of septumOlfactory tubercle
160Orbital area ventrolateral partSupraoptic nucleus
161Posterior pretectal nucleusDorsal part of the lateral geniculate complex
162Nucleus of the posterior commissureMedial preoptic nucleus
163Nucleus of DarkschewitschPosterior complex of the thalamus
164Frontal pole cerebral cortexOrbital area lateral part
165Anterior group of the dorsal thalamusVentral anterior-lateral complex of the thalamus
166Vestibular nucleiOrbital area ventrolateral part
167Ventral posterior complex of the thalamusLateral dorsal nucleus of thalamus
168Orbital area lateral partSubstantia innominata
169Ansiform lobuleDiagonal band nucleus
170Ventral anterior-lateral complex of the thalamusAnterior olfactory nucleus
171Anterodorsal nucleusPrimary somatosensory area barrel field
172Septofimbrial nucleusAnterior hypothalamic nucleus
173Paracentral nucleusMedial amygdalar nucleus
174Posterior complex of the thalamusBed nuclei of the stria terminalis
175Ventral medial nucleus of the thalamusVentral posterior complex of the thalamus
176Central lateral nucleus of the thalamusFrontal pole cerebral cortex
177Lateral dorsal nucleus of thalamusLateral posterior nucleus of the thalamus
178Parafascicular nucleusBed nucleus of the accessory olfactory tract
Pearson correlation matrices for showing functional connectivity measures of each treatment. Download Figure 3-1, TIF file.

Graph theory identification of functional networks

We used a graph theory-based approach to identify the functional neural networks that were associated with each treatment condition. Graph theory is a branch of mathematics that is used to analyze complex networks, such as social, financial, protein, and neural networks (Jeong et al., 2001; Barabasi, 2009; Chiang et al., 2011; Varshney et al., 2011; Babu et al., 2012; Jarrell et al., 2012; Bargmann and Marder, 2013; Wheeler et al., 2013; Oh et al., 2014; Markov et al., 2014; Cohen and D’Esposito, 2016; Vetere et al., 2017). Using graph theory, functional networks can be delineated, and key brain regions of the network can be identified (Sporns et al., 2007; Rubinov and Sporns, 2010; Wheeler et al., 2013; Vetere et al., 2017). Previous studies of regional functional connectivity profiles using Fos have focused on global measures of connectivity (e.g., degree; Wheeler et al., 2013). However, in correlation-based networks, these measures can be strongly influenced by the size of the subnetwork (module) in which a node participates (Power et al., 2013). For the graph theory analyses, we were interested in regional properties and not module size per se. Thus, module structure needs to be considered when examining the role that each region plays in the network. To accomplish this, we used two widely used centrality metrics that were designed for application to modular systems. The Z-scored version of within-module degree (WMDz) indexes the relative importance of a region within its own module (e.g., intramodule connectivity), and the participation coefficient (PC) indexes the extent to which a region connects diversely to multiple modules (e.g., intermodule connectivity; Guimera and Nunes Amaral, 2005). We used the Pearson correlation values that were calculated for the brain regions from each treatment. Before plotting and calculating regional connectivity metrics, the network was thresholded to remove any edges that were weaker than R = 0.75. As such, visualization and graph theory analyses were performed using only edges with positive weights. Regional connectivity metrics (PC and WMDz) were calculated as originally defined by Guimera and Nunes Amaral (2005), modified for application to networks with weighted edges. PC and WMDz were calculated using a customized version of the bctpy Python package (https://github.com/aestrivex/bctpy), which is derived from the MATLAB implementation of Brain Connectivity Toolbox (Rubinov and Sporns, 2010). For WMDz, let (within-module degree) be the summed weight of all edges between region and other regions in module . Then, is the average within-module degree of all regions in module , and is the standard deviation of those values. The WMDz is then defined as: This provides a measure of the extent to which each region is connected to other regions in the same module. For PC, let (between-module degree) be the summed weight of all edges between region and regions in module , and let (total degree) be the summed weight of all edges between region and all other regions in the network. The PC of each region is then defined as: This provides a measure of the extent to which the connections of a region are distributed mostly within its own module (PC approaching 0) or distributed evenly among all modules (PC approaching 1). A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. Previous studies have used ranges of ≥0.30–0.80 for high PC and ≥1.5–2.5 for high WMDz (Guimera and Nunes Amaral, 2005; Cohen and D’Esposito, 2016). Because of differences in the sizes/types of networks that were examined and the methods that were used (e.g., Fos vs functional magnetic resonance imaging), we adjusted the range for consideration as having high PC and WMDz accordingly. Network visualization was performed using a combination of Gephi 0.9.2 software (Bastian et al., 2009) and Adobe Illustrator software. Nodes were positioned using the Force Atlas 2 algorithm (Jacomy et al., 2014) with a handful of nodes that were repositioned manually for better visual organization.

Results

Psychostimulant withdrawal induces restructuring of brain functional networks

We examined the ways in which withdrawal from different psychostimulants alters functional connectivity and modular structuring of the brain. For an overview of the experimental design and analysis pipeline, see Figure 1. Representative examples Fos images collected can be seen in Figure 2. For all of the drugs tested, acute withdrawal produced widespread increases in the functional connectivity of brain regions compared with saline controls (Fig. 3). Importantly, modular structuring of the brain decreased in response to withdrawal from each psychostimulant compared with controls. When using a threshold of 50% of tree height, saline control mice exhibited a modular structure of the brain that contained seven modules, whereas cocaine mice had four modules, methamphetamine mice had three modules, and nicotine mice had five modules and one isolated brain region that was not grouped with any other region (i.e., interanterodorsal nucleus of the thalamus; Fig. 3). Notably, the decrease in the number of modules during withdrawal was independent of the clustering thresholds that were used (Fig. 3). These data indicate that psychostimulant withdrawal decreases modularity of the functional network compared with controls.

Characterization of individual network features

To further characterize the features of each individual network, we used a graph theory approach to identify potential hub brain regions with the most intramodular and intermodular connectivity, which may drive activity within the network and thus be critical for neuronal function in the withdrawal state. We examined positive connectivity (thresholded to a Pearson correlation coefficient >0.75 [0.75R] for inclusion as a network connection) for the network for each treatment and used the modular organization that was identified by hierarchical clustering to partition the regions of the networks. The 0.75R threshold was chosen because all of the brain regions in each network showed connections to other regions at this threshold. Previous animal model studies used various thresholds, ranging from 0.3R to 0.85R (Wheeler et al., 2013; Orsini et al., 2018), to examine connectivity. Negative network connectivity was not examined herein because the precise meaning of such connectivity is controversial and thus is not often examined in network-based approaches (Giove et al., 2009; Meunier et al., 2009; Murphy et al., 2009; Chen et al., 2011). We determined the PC (i.e., a measure of importance for intermodular connectivity) and the WMDz (i.e., a measure of importance for intramodular connectivity; Guimera and Nunes Amaral, 2005) for all brain regions in the networks. A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. Overall, the control and nicotine networks showed much greater intermodular connectivity (high PC) and a great number of regions with both high intermodular and intramodular connectivity (high PC and WMDz). The cocaine and methamphetamine networks showed higher levels of intramodular connectivity (high WMDz) and a low number of regions with intermodular connectivity (Fig. 4). We named each module in each network based on the group of brain regions with the highest WMDz score in the module and considered these regions to be drivers of activity within individual modules (Figs. 5-8 for names).
Figure 4.

Intramodular (WMDz) and intermodular (PC) network features of each treatment. A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. , Highlights of several regions with high PC in each module of each network (see Table 1 for names of abbreviations). , Highlights of several regions with high WMDz (red, higher; blue, lower) in each module of each network. Note that the WMDz color intensity is only relative to the other regions within the same network and not other networks (see Table 1 for names of abbreviations). , Total number of brain regions that accounted for high PC, high WMDz, or both in each network. The control and nicotine networks showed much greater intermodular connectivity and a greater number of regions with both high intermodular and intramodular connectivity. The cocaine and methamphetamine networks showed higher levels of intramodular connectivity and a low number of regions with intermodular connectivity.

Figure 5.

Neural network of control mice thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure.

Figure 8.

Neural network of nicotine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure.

Intramodular (WMDz) and intermodular (PC) network features of each treatment. A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. , Highlights of several regions with high PC in each module of each network (see Table 1 for names of abbreviations). , Highlights of several regions with high WMDz (red, higher; blue, lower) in each module of each network. Note that the WMDz color intensity is only relative to the other regions within the same network and not other networks (see Table 1 for names of abbreviations). , Total number of brain regions that accounted for high PC, high WMDz, or both in each network. The control and nicotine networks showed much greater intermodular connectivity and a greater number of regions with both high intermodular and intramodular connectivity. The cocaine and methamphetamine networks showed higher levels of intramodular connectivity and a low number of regions with intermodular connectivity. Neural network of control mice thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure. Neural network of cocaine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure. Neural network of methamphetamine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure. Neural network of nicotine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure.

The control network is driven by sensory-motor regions

The saline control network had 3176 total functional connections and consisted of seven modules, many of which were heavily driven by sensory-motor brain regions. Of these seven modules, five contained several sensory or motor brain regions that were ranked in the top five for intramodular connectivity (high WMDz). In most cases, a separate set of thalamic brain regions was responsible for intermodular connectivity (high PC; see Table 2 for a full list of values for the network). Overall, the control network had more brain regions with high WMDz, high PC, or both in individual modules compared with other networks. This indicates a more interconnected network with more hub regions (Figs. 2, 3).
Table 2

Saline network values

Brain regionModulePCWMDz
Agranular insular area posterior part30.35−0.48
Agranular insular area ventral part30.150.56
Anterior cingulate area dorsal part30.220.49
Anterior cingulate area ventral part30.470.34
Anterior olfactory nucleus40.500.02
Anterolateral visual area10.650.53
Anteromedial visual area30.310.99
Cortical amygdalar area posterior part70.72−0.69
Dentate gyrus10.49−0.46
Dorsal auditory area50.480.87
Dorsal peduncular area30.080.66
Ectorhinal area50.58−0.57
Entorhinal area lateral part50.400.89
Entorhinal area medial part50.630.20
Fasciola cinerea10.60−0.26
Field CA110.52−0.04
Field CA250.411.11
Field CA360.520.08
Frontal pole cerebral cortex40.460.59
Gustatory areas30.26−0.79
Induseum griseum20.64−1.94
Infralimbic area30.420.59
Lateral visual area10.630.54
Nucleus of the lateral olfactory tract50.50−1.57
Orbital area lateral part30.47−0.09
Orbital area medial part30.29−0.10
Orbital area ventrolateral part30.25−1.76
Parasubiculum10.38−0.78
Perirhinal area50.440.75
Piriform area30.66−2.98
Piriform-amygdalar area70.441.21
Posterior auditory area50.321.25
Posterolateral visual area10.610.72
Posteromedial visual area30.460.19
Postpiriform transition area50.47−0.83
Postsubiculum10.34−0.78
Prelimbic area30.59−2.32
Presubiculum10.490.42
Primary auditory area50.090.94
Primary motor area30.420.73
Primary somatosensory area barrel field30.190.28
Primary somatosensory area lower limb30.410.76
Primary somatosensory area mouth40.450.40
Primary somatosensory area nose40.500.57
Primary somatosensory area trunk30.340.84
Primary somatosensory area upper limb30.040.97
Primary visual area10.530.94
Retrosplenial area dorsal part30.470.22
Retrosplenial area lateral agranular part30.49−0.27
Retrosplenial area ventral part10.591.30
Secondary motor area30.420.65
Subiculum20.500.25
Supplemental somatosensory area40.500.56
Taenia tecta30.25−0.68
Temporal association areas50.400.38
Ventral auditory area50.321.17
Visceral area40.21−2.23
Basolateral amygdalar nucleus70.000.99
Claustrum30.39−1.94
Endopiriform nucleus70.50−0.93
Lateral amygdalar nucleus50.28−0.60
Posterior amygdalar nucleus20.570.18
Anterior amygdalar area30.21−1.32
Bed nucleus of the accessory olfactory tract50.62−1.74
Caudoputamen30.46−2.69
Central amygdalar nucleus70.00−0.01
Fundus of striatum10.49−0.47
Intercalated amygdalar nucleus40.390.87
Lateral septal complex30.430.60
Medial amygdalar nucleus60.581.02
Nucleus accumbens10.48−1.18
Olfactory tubercle70.500.51
Septofimbrial nucleus30.460.44
Bed nuclei of the stria terminalis30.460.21
Diagonal band nucleus70.620.39
Globus pallidus external segment70.48−2.08
Globus pallidus internal segment50.390.38
Magnocellular nucleus50.31−0.02
Medial septal nucleus30.470.29
Substantia innominata20.500.69
Triangular nucleus of septum10.58−0.37
Anterior group of the dorsal thalamus10.50−1.82
Anterodorsal nucleus10.62−0.25
Anteroventral nucleus of thalamus30.33−1.54
Central lateral nucleus of the thalamus30.480.09
Central medial nucleus of the thalamus40.290.91
Dorsal part of the lateral geniculate complex50.130.17
Interanterodorsal nucleus of the thalamus10.591.15
Interanteromedial nucleus of the thalamus60.77−1.38
Intergeniculate leaflet of the lateral geniculate complex50.600.22
Intermediodorsal nucleus of the thalamus40.75−1.36
Lateral dorsal nucleus of thalamus30.340.94
Lateral habenula20.500.53
Lateral posterior nucleus of the thalamus10.47−1.86
Medial geniculate complex20.500.88
Medial habenula40.180.55
Mediodorsal nucleus of thalamus30.51−0.33
Nucleus of reuniens20.490.64
Paracentral nucleus20.490.88
Parafascicular nucleus20.550.85
Parataenial nucleus60.82−2.30
Paraventricular nucleus of the thalamus40.180.49
Peripeduncular nucleus20.500.83
Posterior complex of the thalamus50.40−1.44
Posterior limiting nucleus of the thalamus70.48−0.86
Reticular nucleus of the thalamus50.500.77
Submedial nucleus of the thalamus20.471.02
Subparafascicular nucleus20.481.22
Thalamus sensory-motor cortex related20.53−0.14
Ventral anterior-lateral complex of the thalamus50.43−1.98
Ventral medial nucleus of the thalamus20.57−0.13
Ventral part of the lateral geniculate complex60.590.18
Ventral posterior complex of the thalamus20.61−1.67
Ventral posterolateral nucleus of the thalamus50.540.28
Anterior hypothalamic nucleus10.610.85
Anterodorsal preoptic nucleus30.410.72
Anteroventral periventricular nucleus30.460.32
Anteroventral preoptic nucleus70.490.16
Arcuate hypothalamic nucleus20.63−1.47
Dorsal premammillary nucleus50.60−1.76
Dorsomedial nucleus of the hypothalamus10.49−1.35
Lateral hypothalamic area10.59−0.01
Lateral preoptic area30.281.02
Mammillary body50.100.84
Medial preoptic area40.77−1.38
Medial preoptic nucleus30.410.72
Median preoptic nucleus30.260.76
Parastrial nucleus10.650.47
Parasubthalamic nucleus10.531.06
Paraventricular hypothalamic nucleus30.460.18
Paraventricular hypothalamic nucleus descending division10.72−2.34
Periventricular hypothalamic nucleus posterior part20.58−0.54
Periventricular hypothalamic nucleus preoptic part30.330.84
Periventricular zone30.430.53
Posterior hypothalamic nucleus20.63−1.46
Preparasubthalamic nucleus20.59−0.72
Retrochiasmatic area60.630.59
Subparaventricular zone30.460.36
Subthalamic nucleus20.58−1.93
Suprachiasmatic nucleus30.440.53
Supramammillary nucleus30.161.01
Supraoptic nucleus30.28−0.67
Tuberal nucleus20.560.42
Ventrolateral preoptic nucleus70.361.31
Ventromedial hypothalamic nucleus20.61−1.47
Zona incerta60.560.11
Anterior pretectal nucleus10.52−0.52
Cuneiform nucleus10.630.99
Inferior colliculus10.530.95
Interpeduncular nucleus20.61−1.72
Medial pretectal area10.63−2.05
Midbrain reticular nucleus20.480.43
Midbrain reticular nucleus retrorubral area10.500.44
Nucleus of Darkschewitsch10.49−0.33
Nucleus of the brachium of the inferior colliculus20.59−0.55
Nucleus of the optic tract10.52−1.41
Nucleus of the posterior commissure10.500.04
Olivary pretectal nucleus30.470.12
Parabigeminal nucleus60.541.00
Pedunculopontine nucleus20.490.60
Periaqueductal gray10.640.39
Posterior pretectal nucleus20.500.52
Precommissural nucleus10.640.72
Red nucleus20.60−0.92
Substantia nigra compact part20.500.69
Substantia nigra reticular part60.570.13
Superior colliculus motor related10.601.32
Superior colliculus sensory related10.541.10
Ventral tegmental area20.560.37
Pons60.630.57
Pons motor related10.550.67
Pontine reticular nucleus10.650.52
Vestibular nuclei10.581.16
Ansiform lobule50.600.30
Central lobule20.511.22
Culmen20.510.28
Paraflocculus20.461.16
Simple lobule20.470.98
Saline network values

The cocaine withdrawal network is driven by cortico-thalamo-hypothalamic regions

The cocaine network had 7127 total functional connections and consisted of four modules, one with the majority of all brain regions and three others with a small subset of regions. In the large module (module 1; 144 brain regions), nearly one-third (32%) of the total brain regions within the module (i.e., a mixed set of midbrain-cortico-thalamic-hypothalamic-amygdalar brain regions) had high WMDz. The brain regions that drive intramodular connectivity (high WMDz) in this module did not have any intermodular connectivity (PC). Interestingly, only three brain regions in this module (subparaventricular zone, lateral posterior nucleus of the thalamus, and frontal pole cerebral cortex) reached the criterion (PC ≥ 0.30) for a high level of intermodular connectivity, suggesting sparse communication with other modules. One of the smaller modules, a septal (triangular nucleus of the septum) and cortical (e.g., secondary motor area and dorsal anterior cingulate area) module (module 3) had a different set of thalamic brain regions that had high PC. The other two smaller modules, a prefrontal-habenular module [module 4; dorsal peduncular area (DP), induseum griseum, and lateral habenula] and a thalamic (parafascicular nucleus, mediodorsal nucleus of the thalamus, and ventral medial nucleus of the thalamus), midbrain (nucleus of the posterior commissure), and striatal (bed nucleus of the accessory olfactory tract) module (module 2) contained regions with both a high WMDz and high PC, suggesting that these regions may be potential hubs within the network. Overall, the cocaine network contained the highest number of functional connections in any network but had minimal interconnection between modules (Figs. 2, 4; see Table 3 for a full list of values for the network).
Table 3

Cocaine network values

Brain regionModulePCWMDz
Agranular insular area posterior part10.07−0.69
Agranular insular area ventral part10.22−0.76
Anterior cingulate area dorsal part30.340.93
Anterior cingulate area ventral part10.21−0.30
Anterior olfactory nucleus30.41−0.32
Anterolateral visual area10.090.74
Anteromedial visual area10.050.80
Cortical amygdalar area posterior part10.16−0.72
Dentate gyrus10.020.36
Dorsal auditory area10.050.35
Dorsal peduncular area40.320.71
Ectorhinal area10.011.37
Entorhinal area lateral part10.041.05
Entorhinal area medial part10.17−0.58
Fasciola cinerea30.47−0.19
Field CA110.020.71
Field CA210.02−0.11
Field CA310.050.89
Frontal pole cerebral cortex10.32−1.86
Gustatory areas10.21−0.85
Induseum griseum40.550.71
Infralimbic area10.25−1.28
Lateral visual area10.001.11
Nucleus of the lateral olfactory tract10.18−0.41
Orbital area lateral part10.100.66
Orbital area medial part10.070.39
Orbital area ventrolateral part10.041.10
Parasubiculum20.53−0.16
Perirhinal area10.050.61
Piriform area10.000.47
Piriform-amygdalar area10.17−0.63
Posterior auditory area10.070.11
Posterolateral visual area10.001.58
Posteromedial visual area10.13−1.88
Postpiriform transition area10.100.52
Postsubiculum20.60−0.47
Prelimbic area10.23−1.08
Presubiculum10.28−1.55
Primary auditory area10.001.19
Primary motor area10.120.37
Primary somatosensory area barrel field10.070.31
Primary somatosensory area lower limb10.19−0.44
Primary somatosensory area mouth30.290.47
Primary somatosensory area nose30.25−0.72
Primary somatosensory area trunk10.021.01
Primary somatosensory area upper limb10.160.07
Primary visual area10.060.92
Retrosplenial area dorsal part10.020.80
Retrosplenial area lateral agranular part10.001.32
Retrosplenial area ventral part20.17−0.53
Secondary motor area30.320.95
Subiculum10.22−0.86
Supplemental somatosensory area10.14−1.08
Taenia tecta10.13−0.63
Temporal association areas10.011.19
Ventral auditory area10.020.81
Visceral area10.12−0.03
Basolateral amygdalar nucleus10.030.83
Claustrum10.08−0.82
Endopiriform nucleus10.001.06
Lateral amygdalar nucleus10.07−0.35
Posterior amygdalar nucleus10.14−0.55
Anterior amygdalar area10.000.83
Bed nucleus of the accessory olfactory tract20.420.84
Caudoputamen10.27−1.88
Central amygdalar nucleus10.060.13
Fundus of striatum10.19−1.88
Intercalated amygdalar nucleus10.030.97
Lateral septal complex10.20−0.72
Medial amygdalar nucleus10.24−1.74
Nucleus accumbens10.150.13
Olfactory tubercle10.001.23
Septofimbrial nucleus10.17−0.31
Bed nuclei of the stria terminalis10.110.91
Diagonal band nucleus10.17−1.14
Globus pallidus external segment10.28−1.46
Globus pallidus internal segment10.18−1.30
Magnocellular nucleus10.120.87
Medial septal nucleus10.21−1.35
Substantia innominata10.000.95
Triangular nucleus of septum30.341.31
Anterior group of the dorsal thalamus20.381.78
Anterodorsal nucleus30.48−2.30
Anteroventral nucleus of thalamus30.290.00
Central lateral nucleus of the thalamus10.13−1.96
Central medial nucleus of the thalamus10.16−0.82
Dorsal part of the lateral geniculate complex10.031.01
Interanterodorsal nucleus of the thalamus10.11−0.89
Interanteromedial nucleus of the thalamus10.000.42
Intergeniculate leaflet of the lateral geniculate complex10.12−0.18
Intermediodorsal nucleus of the thalamus30.36−1.56
Lateral dorsal nucleus of thalamus10.120.47
Lateral habenula40.00−1.41
Lateral posterior nucleus of the thalamus10.32−2.30
Medial geniculate complex10.10−0.86
Medial habenula30.470.46
Mediodorsal nucleus of thalamus20.550.82
Nucleus of reuniens10.19−2.35
Paracentral nucleus10.16−1.09
Parafascicular nucleus20.450.18
Parataenial nucleus20.24−0.20
Paraventricular nucleus of the thalamus10.001.09
Peripeduncular nucleus10.03−0.79
Posterior complex of the thalamus10.030.85
Posterior limiting nucleus of the thalamus10.02−0.23
Reticular nucleus of the thalamus10.17−1.27
Submedial nucleus of the thalamus10.150.50
Subparafascicular nucleus10.120.33
Thalamus sensory-motor cortex related10.070.30
Ventral anterior-lateral complex of the thalamus10.13−0.70
Ventral medial nucleus of the thalamus20.66−0.94
Ventral part of the lateral geniculate complex10.11−0.02
Ventral posterior complex of the thalamus10.07−0.50
Ventral posterolateral nucleus of the thalamus20.40−1.10
Anterior hypothalamic nucleus10.061.22
Anterodorsal preoptic nucleus10.001.28
Anteroventral periventricular nucleus20.541.62
Anteroventral preoptic nucleus20.521.08
Arcuate hypothalamic nucleus10.17−0.98
Dorsal premammillary nucleus10.061.26
Dorsomedial nucleus of the hypothalamus10.21−0.49
Lateral hypothalamic area10.070.67
Lateral preoptic area10.100.53
Mammillary body10.22−1.28
Medial preoptic area10.020.83
Medial preoptic nucleus10.15−1.12
Median preoptic nucleus10.13−1.07
Parastrial nucleus10.020.96
Parasubthalamic nucleus10.100.97
Paraventricular hypothalamic nucleus10.22−0.40
Paraventricular hypothalamic nucleus descending division10.130.22
Periventricular hypothalamic nucleus posterior part10.24−1.54
Periventricular hypothalamic nucleus preoptic part10.25−0.91
Periventricular zone30.380.12
Posterior hypothalamic nucleus10.041.47
Preparasubthalamic nucleus10.06−0.14
Retrochiasmatic area10.060.70
Subparaventricular zone10.30−1.46
Subthalamic nucleus20.48−0.73
Suprachiasmatic nucleus10.12−0.77
Supramammillary nucleus10.060.69
Supraoptic nucleus10.001.32
Tuberal nucleus10.001.40
Ventrolateral preoptic nucleus10.07−1.56
Ventromedial hypothalamic nucleus10.130.16
Zona incerta10.11−0.75
Anterior pretectal nucleus10.10−0.21
Cuneiform nucleus10.001.54
Inferior colliculus10.030.94
Interpeduncular nucleus10.06−0.20
Medial pretectal area30.300.84
Midbrain reticular nucleus10.001.08
Midbrain reticular nucleus retrorubral area10.091.03
Nucleus of Darkschewitsch10.05−0.40
Nucleus of the brachium of the inferior colliculus10.001.60
Nucleus of the optic tract10.070.98
Nucleus of the posterior commissure20.360.33
Olivary pretectal nucleus10.21−0.61
Parabigeminal nucleus10.090.20
Pedunculopontine nucleus10.050.90
Periaqueductal gray10.120.70
Posterior pretectal nucleus10.06−1.07
Precommissural nucleus20.24−0.50
Red nucleus10.011.32
Substantia nigra compact part10.011.18
Substantia nigra reticular part10.001.23
Superior colliculus motor related10.110.71
Superior colliculus sensory related10.11−0.05
Ventral tegmental area10.110.26
Pons10.011.03
Pons motor related10.21−1.09
Pontine reticular nucleus10.020.98
Vestibular nuclei20.19−2.26
Ansiform lobule10.15−1.44
Central lobule10.20−0.79
Culmen20.560.82
Paraflocculus10.17−1.50
Simple lobule20.41−0.57
Cocaine network values

The methamphetamine withdrawal network is driven by thalamic regions

The methamphetamine network had 3182 functional connections and consisted of three modules, one with the majority of all brain regions and two others with a small subset of regions. In the large module (module 1), a group of thalamic (e.g., intermediodorsal nucleus of the thalamus, paraventricular nucleus of the thalamus, intergeniculate leaflet of the lateral geniculate complex, and ventral part of the lateral geniculate complex) and amygdalar (intercalated amygdala, central amygdala, and lateral amygdala) regions had high WMDz, but these brain regions did not have any intermodular connectivity (PC), and a separate set of hypothalamic, cortical, and mid/hindbrain regions was responsible for intermodular connectivity. The second module (module 2) had several hypothalamic (e.g., mammillary body, ventrolateral preoptic nucleus, and tuberal nucleus) and pallidal (globus pallidus and internal segment) brain regions with high WMDz and a separate set of cortical regions (e.g., DP and orbital area, ventral part) and midbrain regions (e.g., posterior pretectal nucleus, nucleus of the posterior commissure, and nucleus of Darkschewitsch) that had high interconnectivity with other modules (high PC). The third module (module 3), a thalamic module, had several thalamic regions with high WMDz (e.g., ventral medial nucleus of the thalamus, posterior complex of the thalamus, parafascicular nucleus, and lateral dorsal nucleus of the thalamus). Interestingly, within this module, a separate set of thalamic regions (e.g., paracentral nucleus, ventral anterior-lateral complex of the thalamus, ventral posterior complex of the thalamus, and anterodorsal nucleus) had high PC, indicating that this module is internally directed by thalamic regions and also externally communicates through these regions. Overall, the methamphetamine network had a similar number of total connections to the control network, but it had minimal interconnections between modules (Figs. 2, 5; see Table 4 for a full list of values for the network).
Table 4

Methamphetamine network values

Brain regionModulePCWMDz
Agranular insular area posterior part10.00−0.90
Agranular insular area ventral part10.000.64
Anterior cingulate area dorsal part10.00−0.08
Anterior cingulate area ventral part10.000.41
Anterior olfactory nucleus10.00−2.01
Anterolateral visual area10.000.65
Anteromedial visual area10.08−1.15
Cortical amygdalar area posterior part10.09−0.41
Dentate gyrus10.32−1.31
Dorsal auditory area10.000.67
Dorsal peduncular area20.67−0.41
Ectorhinal area10.000.81
Entorhinal area lateral part10.000.70
Entorhinal area medial part10.00−0.26
Fasciola cinerea20.38−0.46
Field CA110.18−1.45
Field CA210.10−1.36
Field CA310.00−0.84
Frontal pole cerebral cortex20.43−1.01
Gustatory areas10.07−1.09
Induseum griseum10.000.05
Infralimbic area10.13−1.04
Lateral visual area10.001.30
Nucleus of the lateral olfactory tract10.07−1.03
Orbital area lateral part30.50−0.59
Orbital area medial part10.18−1.44
Orbital area ventrolateral part20.63−0.41
Parasubiculum10.000.95
Perirhinal area10.000.61
Piriform area10.00−0.10
Piriform-amygdalar area10.000.11
Posterior auditory area10.05−0.25
Posterolateral visual area10.35−1.44
Posteromedial visual area10.00−0.29
Postpiriform transition area10.002.19
Postsubiculum10.000.92
Prelimbic area10.00−1.01
Presubiculum10.000.98
Primary auditory area10.001.01
Primary motor area10.00−0.94
Primary somatosensory area barrel field10.00−0.18
Primary somatosensory area lower limb10.08−1.08
Primary somatosensory area mouth10.00−1.12
Primary somatosensory area nose10.00−0.26
Primary somatosensory area trunk10.07−0.97
Primary somatosensory area upper limb10.07−1.08
Primary visual area10.41−1.52
Retrosplenial area dorsal part10.17−1.33
Retrosplenial area lateral agranular part10.040.18
Retrosplenial area ventral part20.00−1.56
Secondary motor area10.00−1.40
Subiculum10.001.00
Supplemental somatosensory area10.00−1.37
Taenia tecta10.09−1.18
Temporal association areas10.000.66
Ventral auditory area10.000.15
Visceral area10.07−1.11
Basolateral amygdalar nucleus10.000.35
Claustrum10.000.54
Endopiriform nucleus10.000.93
Lateral amygdalar nucleus10.001.26
Posterior amygdalar nucleus10.000.01
Anterior amygdalar area10.001.07
Bed nucleus of the accessory olfactory tract10.000.51
Caudoputamen10.000.87
Central amygdalar nucleus10.001.21
Fundus of striatum10.06−0.84
Intercalated amygdalar nucleus10.002.04
Lateral septal complex10.06−0.83
Medial amygdalar nucleus10.06−0.61
Nucleus accumbens10.00−0.05
Olfactory tubercle10.32−1.28
Septofimbrial nucleus30.45−0.71
Bed nuclei of the stria terminalis20.430.28
Diagonal band nucleus10.05−0.24
Globus pallidus external segment10.00−0.20
Globus pallidus internal segment20.502.18
Magnocellular nucleus10.00−0.13
Medial septal nucleus10.000.49
Substantia innominata10.000.66
Triangular nucleus of septum20.610.15
Anterior group of the dorsal thalamus20.00−1.56
Anterodorsal nucleus30.45−0.61
Anteroventral nucleus of thalamus20.480.85
Central lateral nucleus of the thalamus30.00−0.03
Central medial nucleus of the thalamus10.00−0.30
Dorsal part of the lateral geniculate complex20.47−0.90
Interanterodorsal nucleus of the thalamus10.00−0.67
Interanteromedial nucleus of the thalamus10.00−1.28
Intergeniculate leaflet of the lateral geniculate complex10.001.80
Intermediodorsal nucleus of the thalamus10.002.04
Lateral dorsal nucleus of thalamus30.000.81
Lateral habenula10.41−1.97
Lateral posterior nucleus of the thalamus10.16−1.32
Medial geniculate complex10.000.87
Medial habenula10.00−0.19
Mediodorsal nucleus of thalamus10.000.08
Nucleus of reuniens10.001.27
Paracentral nucleus30.50−1.38
Parafascicular nucleus30.000.85
Parataenial nucleus10.000.74
Paraventricular nucleus of the thalamus10.001.82
Peripeduncular nucleus10.000.33
Posterior complex of the thalamus30.001.48
Posterior limiting nucleus of the thalamus10.00−0.12
Reticular nucleus of the thalamus10.04−0.11
Submedial nucleus of the thalamus20.00−0.90
Subparafascicular nucleus10.001.36
Thalamus sensory-motor cortex related10.000.57
Ventral anterior-lateral complex of the thalamus30.45−1.28
Ventral medial nucleus of the thalamus30.001.54
Ventral part of the lateral geniculate complex10.001.48
Ventral posterior complex of the thalamus30.50−0.68
Ventral posterolateral nucleus of the thalamus10.000.54
Anterior hypothalamic nucleus10.000.69
Anterodorsal preoptic nucleus10.06−0.84
Anteroventral periventricular nucleus10.001.34
Anteroventral preoptic nucleus10.001.23
Arcuate hypothalamic nucleus20.50−0.32
Dorsal premammillary nucleus10.07−0.82
Dorsomedial nucleus of the hypothalamus10.000.39
Lateral hypothalamic area10.00−1.22
Lateral preoptic area10.040.14
Mammillary body20.500.98
Medial preoptic area10.000.53
Medial preoptic nucleus10.000.75
Median preoptic nucleus10.00−0.14
Parastrial nucleus10.000.86
Parasubthalamic nucleus10.000.82
Paraventricular hypothalamic nucleus10.001.36
Paraventricular hypothalamic nucleus descending division10.000.75
Periventricular hypothalamic nucleus posterior part10.11−0.62
Periventricular hypothalamic nucleus preoptic part10.000.65
Periventricular zone10.000.14
Posterior hypothalamic nucleus10.000.52
Preparasubthalamic nucleus10.00−0.08
Retrochiasmatic area10.43−1.79
Subparaventricular zone10.001.26
Subthalamic nucleus10.07−0.83
Suprachiasmatic nucleus10.44−1.61
Supramammillary nucleus10.00−0.11
Supraoptic nucleus10.07−0.73
Tuberal nucleus20.500.97
Ventrolateral preoptic nucleus20.491.53
Ventromedial hypothalamic nucleus10.41−1.83
Zona incerta10.001.35
Anterior pretectal nucleus10.00−0.98
Cuneiform nucleus20.441.64
Inferior colliculus10.001.08
Interpeduncular nucleus10.05−0.36
Medial pretectal area10.000.45
Midbrain reticular nucleus10.000.65
Midbrain reticular nucleus retrorubral area10.001.08
Nucleus of Darkschewitsch20.600.27
Nucleus of the brachium of the inferior colliculus10.001.09
Nucleus of the optic tract10.000.27
Nucleus of the posterior commissure20.63−0.23
Olivary pretectal nucleus10.10−1.47
Parabigeminal nucleus10.000.57
Pedunculopontine nucleus10.000.86
Periaqueductal gray10.00−0.01
Posterior pretectal nucleus20.63−0.27
Precommissural nucleus10.000.85
Red nucleus10.04−0.18
Substantia nigra compact part10.000.80
Substantia nigra reticular part10.30−1.69
Superior colliculus motor related10.001.18
Superior colliculus sensory related10.001.79
Ventral tegmental area10.11−1.43
Pons10.14−0.54
Pons motor related10.47−1.84
Pontine reticular nucleus10.09−0.34
Vestibular nuclei30.001.21
Ansiform lobule30.50−0.60
Central lobule10.000.14
Culmen10.000.23
Paraflocculus20.640.22
Simple lobule20.26−1.03
Methamphetamine network values

The nicotine withdrawal network is driven by cortical and extended amygdalar regions

The nicotine network had 4957 functional connections, the second most of all conditions, and consisted of five modules and one brain region (interanterodorsal nucleus of the thalamus) that was disconnected from the entire network. Overall, the nicotine network was relatively interconnected between modules and had two large modules and three medium modules. One of the large modules (module 1) contained midbrain (e.g., pedunculopontine nucleus and periaqueductal gray), hindbrain (e.g., pons and pontine reticular nucleus), cortical (e.g., perirhinal area, posterior auditory area, ventral anterior cingulate temporal association areas, and visceral area), and subcortical (claustrum) brain regions that had high WMDz. A separate set of cortical (e.g., postsubiculum, lateral visual area, and gustatory areas), thalamic (e.g., anteroventral nucleus of the thalamus and peripeduncular nucleus), hypothalamic (e.g., posterior periventricular nucleus, supramammillary nucleus, and periventricular zone), and midbrain (e.g., midbrain reticular nucleus, ventral tegmental area, and medial pretectal area) brain regions and a few others that included the central amygdala and vestibular nuclei had high PC. In the second large module (module 4), a set of sensory/cortical [e.g., primary somatosensory area, lower limb, ventral agranular insular area (AIv), and primary motor area] and hypothalamic (e.g., parastriatal nucleus, retrochiasmatic area, lateral preoptic area, medial preoptic area, and zona incerta) brain regions had high WMDz. All of the same sensory/cortical and hypothalamic regions had high PC and a number of other thalamic and sensory regions. Additionally, the anterior amygdalar area (AAA) also showed both high WMDz and high PC. One of the smaller modules (module 2) consisted of hippocampal (dentate gyrus) and sensory/cortical (e.g., posterolateral visual area, anteromedial visual area, and subiculum [SUB]) regions, along with the nucleus of reuniens (RE) with high WMDz. The SUB and RE also had high PC, along with other thalamic, hypothalamic, and midbrain regions. In another smaller module (module 3), the precommissural nucleus (PRC), medial habenula, and intergeniculate leaflet of the lateral geniculate complex (IGL) had high WMDz and high PC. Other midbrain and thalamic regions also had high PC. In the last small module (module 5), no regions reached the criterion for high WMDz, but the orbitofrontal cortex (lateral and ventrolateral orbital area), bed nucleus of the stria terminalis, and medial amygdalar nucleus were all in the top five values (WMDz = 0.64–0.67). However, every region in this module, with the exception of the bed nucleus of the accessory olfactory tract, reached the criterion for high PC (Figs. 2, 6; see Table 5 for a full list of values for the network).
Figure 6.

Neural network of cocaine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1 are represented by different colored edges. See figure key for examples of each representative component of the figure.

Table 5

Nicotine network values

RegionModulePCWMDz
Agranular insular area posterior part10.030.12
Agranular insular area ventral part40.430.85
Anterior cingulate area dorsal part10.170.87
Anterior cingulate area ventral part10.220.94
Anterior olfactory nucleus50.420.27
Anterolateral visual area10.38−0.12
Anteromedial visual area20.570.97
Cortical amygdalar area posterior part10.12−0.46
Dentate gyrus20.580.99
Dorsal auditory area10.200.52
Dorsal peduncular area40.490.33
Ectorhinal area10.130.78
Entorhinal area lateral part10.28−1.50
Entorhinal area medial part40.57−0.12
Fasciola cinerea10.25−0.35
Field CA140.34−0.11
Field CA240.360.33
Field CA340.440.80
Frontal pole cerebral cortex50.49−2.12
Gustatory areas10.44−0.40
Induseum griseum30.47−1.01
Infralimbic area40.420.66
Lateral visual area10.380.27
Nucleus of the lateral olfactory tract40.41−1.16
Orbital area lateral part50.440.67
Orbital area medial part40.48−2.31
Orbital area ventrolateral part50.460.66
Parasubiculum40.590.18
Perirhinal area10.131.02
Piriform area10.000.11
Piriform-amygdalar area10.11−2.62
Posterior auditory area10.120.95
Posterolateral visual area20.550.98
Posteromedial visual area10.38−0.12
Postpiriform transition area10.100.58
Postsubiculum10.340.58
Prelimbic area10.16−1.81
Presubiculum10.270.69
Primary auditory area10.070.85
Primary motor area40.430.82
Primary somatosensory area barrel field50.430.58
Primary somatosensory area lower limb40.441.12
Primary somatosensory area mouth40.61−0.75
Primary somatosensory area nose40.540.67
Primary somatosensory area trunk40.480.70
Primary somatosensory area upper limb40.440.26
Primary visual area40.500.56
Retrosplenial area dorsal part10.260.30
Retrosplenial area lateral agranular part10.210.67
Retrosplenial area ventral part10.200.41
Secondary motor area40.550.27
Subiculum20.660.97
Supplemental somatosensory area10.220.73
Taenia tecta40.530.65
Temporal association areas10.140.93
Ventral auditory area10.090.85
Visceral area10.090.90
Basolateral amygdalar nucleus10.250.71
Claustrum10.181.06
Endopiriform nucleus10.10−0.96
Lateral amygdalar nucleus10.240.36
Posterior amygdalar nucleus40.350.54
Anterior amygdalar area40.520.86
Bed nucleus of the accessory olfactory tract50.13−0.68
Caudoputamen20.61−0.17
Central amygdalar nucleus10.36−0.01
Fundus of striatum20.590.47
Intercalated amygdalar nucleus10.290.46
Lateral septal complex10.22−1.88
Medial amygdalar nucleus50.490.64
Nucleus accumbens40.390.70
Olfactory tubercle40.39−2.16
Septofimbrial nucleus10.16−0.31
Bed nuclei of the stria terminalis50.490.65
Diagonal band nucleus50.44−0.33
Globus pallidus external segment40.49−2.31
Globus pallidus internal segment40.450.27
Magnocellular nucleus40.410.43
Medial septal nucleus20.660.48
Substantia innominata50.460.14
Triangular nucleus of septum30.490.28
Anterior group of the dorsal thalamus40.60−1.42
Anterodorsal nucleus30.53−1.16
Anteroventral nucleus of thalamus10.53−2.45
Central lateral nucleus of the thalamus20.67−1.12
Central medial nucleus of the thalamus10.170.09
Dorsal part of the lateral geniculate complex40.00−2.07
Interanteromedial nucleus of the thalamus10.27−2.07
Intergeniculate leaflet of the lateral geniculate complex30.501.16
Intermediodorsal nucleus of the thalamus10.12−0.71
Lateral dorsal nucleus of thalamus50.470.64
Lateral habenula30.470.75
Lateral posterior nucleus of the thalamus50.44−2.94
Medial geniculate complex10.220.81
Medial habenula30.381.19
Mediodorsal nucleus of thalamus10.230.03
Nucleus of reuniens20.670.86
Paracentral nucleus40.580.66
Parafascicular nucleus20.68−0.14
Parataenial nucleus30.40−0.61
Paraventricular nucleus of the thalamus30.46−1.06
Peripeduncular nucleus10.41−1.81
Posterior complex of the thalamus50.450.26
Posterior limiting nucleus of the thalamus10.21−0.13
Reticular nucleus of the thalamus40.25−0.76
Submedial nucleus of the thalamus40.450.72
Subparafascicular nucleus10.250.99
Thalamus sensory-motor cortex related10.20−0.83
Ventral anterior-lateral complex of the thalamus50.460.27
Ventral medial nucleus of the thalamus40.450.06
Ventral part of the lateral geniculate complex10.210.44
Ventral posterior complex of the thalamus50.480.26
Ventral posterolateral nucleus of the thalamus10.12−2.84
Anterior hypothalamic nucleus50.440.51
Anterodorsal preoptic nucleus40.400.58
Anteroventral periventricular nucleus40.38−0.22
Anteroventral preoptic nucleus40.300.05
Arcuate hypothalamic nucleus20.49−0.42
Dorsal premammillary nucleus20.640.50
Dorsomedial nucleus of the hypothalamus20.610.75
Lateral hypothalamic area40.44−0.06
Lateral preoptic area40.400.85
Mammillary body10.39−0.30
Medial preoptic area40.400.81
Medial preoptic nucleus50.450.50
Median preoptic nucleus40.29−1.51
Parastrial nucleus40.451.11
Parasubthalamic nucleus20.42−0.99
Paraventricular hypothalamic nucleus10.220.88
Paraventricular hypothalamic nucleus descending division20.650.72
Periventricular hypothalamic nucleus posterior part10.340.21
Periventricular hypothalamic nucleus preoptic part40.21−0.74
Periventricular zone10.35−0.50
Posterior hypothalamic nucleus10.280.76
Preparasubthalamic nucleus40.45−2.20
Retrochiasmatic area40.450.98
Subparaventricular zone40.480.07
Subthalamic nucleus40.590.58
Suprachiasmatic nucleus20.61−2.32
Supramammillary nucleus10.370.05
Supraoptic nucleus40.45−2.10
Tuberal nucleus40.490.64
Ventrolateral preoptic nucleus10.22−2.82
Ventromedial hypothalamic nucleus40.490.77
Zona incerta40.500.85
Anterior pretectal nucleus20.68−0.63
Cuneiform nucleus40.400.44
Inferior colliculus10.190.38
Interpeduncular nucleus10.260.06
Medial pretectal area10.33−1.59
Midbrain reticular nucleus10.370.26
Midbrain reticular nucleus retrorubral area10.26−0.19
Nucleus of Darkschewitsch20.69−2.09
Nucleus of the brachium of the inferior colliculus10.220.26
Nucleus of the optic tract30.400.67
Nucleus of the posterior commissure30.490.20
Olivary pretectal nucleus30.440.33
Parabigeminal nucleus30.380.20
Pedunculopontine nucleus10.211.08
Periaqueductal gray10.150.78
Posterior pretectal nucleus30.66−2.16
Precommissural nucleus30.461.21
Red nucleus10.170.68
Substantia nigra compact part20.640.19
Substantia nigra reticular part40.62−0.15
Superior colliculus motor related10.360.45
Superior colliculus sensory related10.250.64
Ventral tegmental area10.37−0.33
Pons10.181.06
Pons motor related10.260.75
Pontine reticular nucleus10.230.82
Vestibular nuclei10.47−1.51
Ansiform lobule10.250.84
Central lobule10.200.76
Culmen10.190.40
Paraflocculus10.27−0.03
Simple lobule10.36−0.48
Nicotine network values Top to bottom order of brain regions in

Discussion

The present study used unbiased single-cell whole-brain imaging to identify changes in brain functional architecture after withdrawal from chronic exposure to psychostimulants. Withdrawal from psychostimulants resulted in increased functional connectivity that was associated with a decrease in modularity with varying degrees of severity, depending on the drug, compared with control mice. This decreased modularity resulted in the emergence of new network architecture and organization of the brain. Using graph theory, we identified brain regions that are most responsible for intermodular and intramodular communication within each network. Withdrawal from all of the psychostimulants that were tested in the present study resulted in different network organization than the control network. The methamphetamine and cocaine withdrawal networks closely resembled each other in structural organization, primarily through thalamic motifs, whereas the nicotine withdrawal network shared some similarities with the control network. These unbiased whole-brain analyses demonstrate that psychostimulant withdrawal produces the drug-dependent remodeling of functional architecture of the brain and suggest that decreased modularity of the brain functional network may be a central feature of withdrawal.

Changes to modularity and structure of the brain caused by psychostimulant withdrawal

We found that cocaine, methamphetamine, and nicotine withdrawal produced major increases in functional connectivity throughout the brain compared with control mice. We further found that withdrawal resulted in a decrease in modular structuring of the brain compared with control mice (seven modules). The decrease in modularity was most evident for methamphetamine withdrawal (three modules) and cocaine withdrawal (four modules), whereas nicotine withdrawal showed a smaller reduction of modularity (five modules). Using the same approaches (i.e., whole-brain network analysis of Fos) reduced modularity after abstinence from alcohol dependence in mice was similarly found (Kimbrough et al., 2020). Further, humans who suffer from dementia and traumatic brain injury have shown reduced modularity that is associated with cognitive deficits (de Haan et al., 2012; Brier et al., 2014; Arnemann et al., 2015; Gallen et al., 2016; Sporns and Betzel, 2016; Bertolero et al., 2018). Changes in network structure/functional connectivity (Tomasi et al., 2010; Konova et al., 2013, 2015; Ma et al., 2015) and cognitive function (Spronk et al., 2013; Ashare et al., 2014; Sabrini et al., 2019) have been observed after chronic drug use and withdrawal, suggesting that similar mechanisms may be active between these different neural disorders.

Features of psychostimulant networks

We examined the components of individual modules within each network and found that the control network was heavily driven by sensory and motor brain regions. This result confers validity to our single-cell whole-brain network analysis approach for characterizing network features because it fits with what might be expected from a normal, awake, behaving animal that explores the environment and relies heavily on sensory/motor systems. Furthermore, the control network was more interconnected between modules overall and contained several regions that could be classified as hubs of each module that are critical for network function, based on high intramodular and intermodular connectivity. This suggests that the control brain may be more resilient to the disruption of function because additional hub regions may compensate more easily in response to such disruptions. In the networks that were associated with withdrawal from psychostimulants, a shift was observed from sensory/motor regions to more subcortical (e.g., amygdalar, thalamic, hypothalamic, and midbrain) regions that drive the network. A similar effect was seen in nonhuman primates after cocaine abstinence (Murnane et al., 2015), and alterations of functional connectivity of the somatosensory cortex are associated with smokers (Claus and Weywadt, 2020). This may represent a shift from top-down cortical network control (Gilbert and Sigman, 2007) to bottom-up subcortical network control and may reflect the greater influence of internal drives that are associated with negative affect during withdrawal in controlling the whole-brain network (Koob, 2015). This shift may be a major reason why drugs are so addictive because higher cortical functional connectivity in humans may protect against relapse (McHugh et al., 2017). Given the modular organization of the different networks, both the control network and nicotine network had a much higher incidence of intermodular connectivity, whereas the methamphetamine and cocaine networks had only a small subset of brain regions that were connected between different modules. Similar changes in neural activity, combined with decreases in interconnectivity and network efficiency, have been observed in humans after psychostimulant use (Ahmadlou et al., 2013; Wang et al., 2015; Liang et al., 2015). The nicotine network was different from the methamphetamine and cocaine networks and somewhat resembled a slightly altered control network. Similarities and differences in network properties of the three different drugs are likely to be caused by differences in receptor mechanisms and locations where each drug acts throughout the brain. Indeed, both cocaine and methamphetamine target the same dopamine transporter, whereas nicotine acts on nicotinic receptors (Rothman and Baumann, 2003; Nestler, 2005; Sulzer et al., 2005; D’Souza and Markou, 2011). The interanterodorsal nucleus of the thalamus was disconnected from the nicotine network, suggesting that it may not be involved in controlling the withdrawal network, although we cannot exclude the possibility that its disconnection may instead be a critical feature of nicotine withdrawal. One of the larger modules in the nicotine network was driven by several brain regions, two of which included the AAA and AIv, which have been suggested to be associated with nicotine withdrawal in humans (Naqvi et al., 2007; Sutherland et al., 2013). The methamphetamine and cocaine networks, although having distinctly different features, shared an overall motif of lower modularity and being heavily driven by thalamic brain regions. This suggests that, in a destabilized and less structured neural network, the thalamus becomes more critical to controlling the whole-brain network. The thalamus is thought to play a major role in relaying information, and the reliance of these networks on this group of regions suggests that the thalamus is not simply a relay station but has greater importance in cognitive and emotional function (Sherman, 2007; Ahissar and Oram, 2015). Substantial evidence corroborates the importance of the thalamus in psychostimulant addiction and withdrawal. In a rat model of cocaine self-administration, the thalamus was found to be heavily involved in network function during acute abstinence, but changes in the network disappeared after two weeks (Orsini et al., 2018). Interestingly, the thalamus in humans has been shown to be hypoactive in cocaine abusers (Tomasi et al., 2007), and thalamic connectivity is predictive of cocaine dependence (Zhang et al., 2016) and altered in infants who are exposed to cocaine (Salzwedel et al., 2016). Although network changes that are induced by acute withdrawal are reversed over time (Orsini et al., 2018), prolonged use may lead to more permanent restructuring of the brain, and major differences between the nicotine and methamphetamine/cocaine networks may account for differences in the severity of each drug after long-term use (Nestler, 2005; Grant et al., 2012; Spronk et al., 2013). In conclusion, in the past 40 years, the substance use disorder field has made tremendous progress by identifying numerous brain regions that are dysregulated after psychostimulant exposure and contribute to withdrawal behaviors (Kalivas and McFarland, 2003; Robinson and Kolb, 2004; Kalivas, 2007; Everitt et al., 2008; Jedynak et al., 2012; Koob and Volkow, 2016; Bobadilla et al., 2017). The present results confirm that a substantial number of brain regions are affected by psychostimulant exposure and suggest that a common pathway that is associated with withdrawal may not reside at the level of brain regions or even single neural circuits. Instead, these results suggest that the main common phenomenon that is observed among all three of these psychostimulants is decreased modularity of whole-brain functional architecture, suggesting that a common feature may reside at the whole-network level. This interpretation is consistent with the literature on the modularity of complex systems, including the brain and mind, showing that lower modularity reduces the capacity of the system to adapt to its environment (Kashtan and Alon, 2005). It is however worth noting that further studies will be necessary to determine whether lower modularity is simply a feature of increased functional connectivity regardless of whether it is because of withdrawal or other mechanisms. One limitation of the present study is that it did not assess withdrawal behaviors after minipump removal for comparison to network changes. This was done to avoid confounds as to the source of Fos production (e.g., withdrawal or behavioral testing). Another limitation of the present study is the lack of direct comparisons between neural activation of each treatment. The approaches used within this study can be leveraged to study and better understand numerous cognitive states (Smith and Kimbrough, 2020; Simpson et al., 2021). However, in the future assessing neural and network differences in more quantitative ways will be necessary. In summary, the present study showed that withdrawal from psychostimulants results in changes in neural network structure, including increases in functional connectivity among brain regions and decreases in modularity. Psychostimulant withdrawal resulted in a shift from a sensory/motor-driven network to a network that is highly driven by subcortical regions. We also found that different psychostimulants do not produce the same neural networks, although methamphetamine and cocaine shared similar properties. These findings shed light on alterations of brain function that are caused by drug exposure and identify potential brain regions that warrant future study. The present study demonstrates that psychostimulant withdrawal produces drug-dependent remodeling of the functional architecture of the brain and suggests that decreased modularity of the brain functional networks may be a common feature of withdrawal. These findings may prove critical to designing future treatment approaches for withdrawal symptoms.
  84 in total

1.  Three-dimensional reconstruction of brain-wide wiring networks in Drosophila at single-cell resolution.

Authors:  Ann-Shyn Chiang; Chih-Yung Lin; Chao-Chun Chuang; Hsiu-Ming Chang; Chang-Huain Hsieh; Chang-Wei Yeh; Chi-Tin Shih; Jian-Jheng Wu; Guo-Tzau Wang; Yung-Chang Chen; Cheng-Chi Wu; Guan-Yu Chen; Yu-Tai Ching; Ping-Chang Lee; Chih-Yang Lin; Hui-Hao Lin; Chia-Chou Wu; Hao-Wei Hsu; Yun-Ann Huang; Jing-Yi Chen; Hsin-Jung Chiang; Chun-Fang Lu; Ru-Fen Ni; Chao-Yuan Yeh; Jenn-Kang Hwang
Journal:  Curr Biol       Date:  2010-12-02       Impact factor: 10.834

2.  Scale-free networks: a decade and beyond.

Authors:  Albert-László Barabási
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

3.  Complex network measures of brain connectivity: uses and interpretations.

Authors:  Mikail Rubinov; Olaf Sporns
Journal:  Neuroimage       Date:  2009-10-09       Impact factor: 6.556

Review 4.  Neurobiology of addiction: a neurocircuitry analysis.

Authors:  George F Koob; Nora D Volkow
Journal:  Lancet Psychiatry       Date:  2016-08       Impact factor: 27.083

5.  Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake.

Authors:  Shkelzen Shabani; Carrie S McKinnon; Christopher L Cunningham; Tamara J Phillips
Journal:  Neuropharmacology       Date:  2011-11-18       Impact factor: 5.250

6.  Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice.

Authors:  Amy F Eisener-Dorman; Laura Grabowski-Boase; Lisa M Tarantino
Journal:  Behav Brain Funct       Date:  2011-08-01       Impact factor: 3.759

7.  Sodium butyrate modulates a methamphetamine-induced conditioned place preference.

Authors:  Jie Zhu; Na Zhao; Yanjiong Chen; Li Zhu; Qing Zhong; Jian Liu; Teng Chen
Journal:  J Neurosci Res       Date:  2016-07-18       Impact factor: 4.164

8.  Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception.

Authors:  Dardo Tomasi; Rita Z Goldstein; Frank Telang; Thomas Maloney; Nelly Alia-Klein; Elisabeth C Caparelli; Nora D Volkow
Journal:  Psychiatry Res       Date:  2007-06-19       Impact factor: 3.222

9.  Structural properties of the Caenorhabditis elegans neuronal network.

Authors:  Lav R Varshney; Beth L Chen; Eric Paniagua; David H Hall; Dmitri B Chklovskii
Journal:  PLoS Comput Biol       Date:  2011-02-03       Impact factor: 4.475

10.  Functional Connectivity of Chronic Cocaine Use Reveals Progressive Neuroadaptations in Neocortical, Striatal, and Limbic Networks.

Authors:  Caitlin A Orsini; Luis M Colon-Perez; Sara C Heshmati; Barry Setlow; Marcelo Febo
Journal:  eNeuro       Date:  2018-07-24
View more
  4 in total

1.  Repeated blast mild traumatic brain injury and oxycodone self-administration produce interactive effects on neuroimaging outcomes.

Authors:  Matthew J Muelbl; Breanna L Glaeser; Alok S Shah; Rachel A Chiariello; Natalie N Nawarawong; Brian D Stemper; Matthew D Budde; Christopher M Olsen
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

Review 2.  Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Authors:  Hanis Mohammad Hazani; Isa Naina Mohamed; Mustapha Muzaimi; Wael Mohamed; Mohamad Fairuz Yahaya; Seong Lin Teoh; Rashidi Mohamed Pakri Mohamed; Mohd Fadzli Mohamad Isa; Sundus Mansoor Abdulrahman; Ravi Ramadah; Mohammad Rahim Kamaluddin; Jaya Kumar
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

3.  SMART: An Open-Source Extension of WholeBrain for Intact Mouse Brain Registration and Segmentation.

Authors:  Michelle Jin; Joseph D Nguyen; Sophia J Weber; Carlos A Mejias-Aponte; Rajtarun Madangopal; Sam A Golden
Journal:  eNeuro       Date:  2022-05-03

Review 4.  From ensembles to meta-ensembles: Specific reward encoding by correlated network activity.

Authors:  Christoph Körber; Wolfgang H Sommer
Journal:  Front Behav Neurosci       Date:  2022-09-08       Impact factor: 3.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.